2023-09-30-accounts

The British Society for Haematology (LiRnited by guarantee) Tiustees, report and consolidated financial statements Registered Company No: 02645706 Registered ch￿'itY No: 100573 5 Year ended 30 September 2023

Tlie Bi'itish SDtiety ftsi. HllcJJilltology ILiDiileJ b}, g￿￿r*jitt¢I Yui. enJe1130 Septtnib¢Y 2023 Trustees, repojl and adminstrative detaÈls ljidependent Ruditoi%' Jrport lo tlie Ineinbers of The Bj'itish Society fov Haematology (Limited by guarantee) CDllsoliddted 5tatern¢iit of finaiicial activities {incoiporating an illcoine aiid expenditure account) Consolidated bala#ce sheet 16 19 20 Coiiipany balaJJce sheet Consolidated Statement of Ca5h-flows 21 22 NDte5 23

The Jlritislj Soriety foi. HllemAtologylLiniil¢(I by gu&i'Aiileel 1'J'u$ttts' I'epfjrt xnd con.%oli(laled filla￿CE￿I $liit¢tDeDIs Yell). end¢(130.Soptember 2023 rhe Trustees present theirannual report and the coiisolidated audited fithanoial slateinents forthe yeartnded 30 September 2023. These financial statements comply wEth current statiitojy require&iients and willi tlie iEquireittettts of the ch8rity's goveiniiig dociimenl and with the Staternenl of Recomtneijded Praotice-"Accoui?ting and Reporting by Chai'ities" Oh'eeilves llndAclivili Tlie objects of the Society, which is a Irgistered cllarity and cojiipany liinited by guai'aiitee, ai'e'to advanee tlie piactice and S￿dY of haeJi?atology aiid to facilitate coijlact betweeji persoJ15 inteiEsted ij) haeinatology" Th¢ chief ways ill wh￿¢11 the Society piirsues thes¢ objects al'e tljj'tsugh its joui'nals,. the prodiictÈon of ¢linÈciil guidelines. it5 Ajinual Srienlific Meeting,. it5 gratjts yi'ogi?mme and educ&tional meetijigs and oth¢i' i'esources. The Trustees confji'm they have refei'red to t]ie guidance fifjm the Charity Conimission oli public benefit and complied with the duty iji Stctiojj 17 of tlie Cliarities Act 2011 to ljave diie regard to tli¢ Comn)ission's piiblic benefit ￿l£danCe. Tlie Tivstees confji'm that tliey l?ave referi'ed to ili¢ guidaiice contaiiied in the Cliarity Cojlliiiission's genejal guidance on publi¢ beiiefit wli¢n Kvicwiiig the Society's ainis and objectives and in planiiiiig future aLtivities. The 8oGiety's new ioi) Statel￿ent places due enipliasis on publio bei)efit. begiiiiiing with this selltence. BSH promotes excellen¢¢ tn the study, reseatch and practice ofiiaernatolo8y foi. th¢ benefit of pi'ofe&%ionals ond tlie wider public" Deiuils IcoiIIAdiyilles Th¢ Society launched its Tjew strategic plRn, Lislgning, LeainiiE, LeLydifrig, in Febtwary 2021. Tlie ¢unEnt Strategy'5 Vision and Mission Staternents are.. B,%H will be the iMernb¢rslup organ￿S*ll￿tt uf fi￿￿t choice foi. all UK haemalology profc.%%ianals, an a8s0¢iation through whi¢h they conncct, 4haiE their leai'ning ai)d provide a highly influential voice on all aspects of hacmatology. BSFI pl￿tnOteS excellet)ce in the study, Tesearch, and practice of haEl￿at010sY for tli¢ benefit Df professionals and the widej. public. The chief ways that BSH acts on its mission are.. providiRg and supportirtg multi-disciplinary education for stu(tcnts and professionals at all level5,' rdising standards of Glinical caiE at]d laboi3tory pr&clice thToirgh guidelitt65 and the provisioll of expert advice,. 3. providiJJg support for research via its publicati4)ns, progratnrncs and grants pl￿VidI￿g nelwoi'king oppoilunitics th&1 bi'iiig haeniatology pi'ofessionals togetli¢r' representing the interests and concerns of ljaematology professionals at t]ational and iiit¢iMational levels iere are three strategi¢ aim5 for the three-yeay lif¢time ofthe plan.. Membei%lEip support tor all MDT profession&ls Icnowledge transfer 3. AdvtsGaGy for haematology and its professionals. Regisiered company llumbBf'. 02645706

Tb¢ Brit1511 S(kcizty ftsi. Ilatniatology Il.Imlted by giiRI'Hnfeel Trll51eY3' 1'ÈpoiI coD501id&tL'd fintyneial $t¥t¢Jii¢Jit5 YCRI. ¢nded 30 September 2b23 In th¢ plan, tlie Society also cominitted to rnaksiig progiess on EDI and ¢iivironmental concerns. The plan is b¢in8 followed up every six Inonths with an iipdate to the Board on piDgiESS made. Signifi¢ant a¢tivities were.. The Annual Science Meeting aDd other educational events PIDvision of the Bfr.liish Joiii'nal of H(7eiKulology {BJHLFgml and the opeii a¢¢es$ journal eJHaein' Gra￿t-l￿ak]lig PLDgidmme' Clincal GEiidelitkes' M¢mbership Advocacy work. We report on diese items in moir detail below. AnJ)ustl Scientific Mccting (ASM) The 2023 BSH ASM was lield as A face to facc meeting at the ICC. Birmiiigham fiDm 23-25 Api'il. with the Pitfalls sessions on SatLlI'day 22 Api'il. This was anotl)er siicce5sfikl me¢ting with 1,486 del¢gales. The ASM contributed to the subb'idiary Inaking a profit of £428,797 for tlie year. Ill spi'ing 2022 BSH bcgan a tet)der process forthe PCO conti2ct, as art exercise in good PTa¢tice, and Confcrence PaTthEr5 Iiilciiiational was awarded tlie contract for & thTee-yeai' period with a oti¢.y¢ar bre2k claiisE. It has been agreed that CPI will coi)tinue with the Ihree-yeai. conti7c¢ lip to 2025, after Mallagi￿g the 2023 tneeting successfully. EdllcAtioll aivir¢ness Overall, the BSI4 spent £1,379,530 on cd(Icattoii and awareness activities compared with £1,134,075 iii 2022, with £145,722 being spent on a Wcjikforcc Sui'v¢y pl￿JeCt. Diiring the year the Society ¢onlributed £5,000 a5 sponsoIBliip of the Anniial 8icklc Ccll & Thalassaemia IASCATI event (2022.. £5,000) as well as sponsoring th¢ RCPath Summer qchty)I with £1,000 {2022: £1,500), illld lh¢ APPG on divErsily and iiiclusion with £2,1>00. L.duGational events havc bcen delivered botli Viltually and face to face, with virt￿al events pi'ovidillg greatti flexibility & opwitunities to the atteijdees. The Society ha5 ir2ve51Ed £116,026 iii tlie BSH web51t¢ during the year (2022.. £237,552) BSH pr(Ivides the BJHaeni to all fEIII and f￿11 Ircduccd) members at a cost lo th¢ Society of £108,555 {2022.' £144,918). IUHaein is Co-owntd by the 8ncicty and the publisher Wiley. Tlie So¢iety and Wiley Ltlso co-own open acces5 jouinal, eJJlaeFJJ, which lias cnabled the publication of additional quality nial¥rial as a vRluablt overtlow frnm ISJHcTem,' th¢ So¢icty iEccived £77,119 in loyalties from eJHaeyiT dui'ing tlie year {2022.' £51,920). Eiieitl. The SoGiety 5 face-to-fa¢e And 4virlual education eventsthroughout theyear,via it5Edii¢atioii Cx>minitteE and Special Interest Groups (SIGS). Tlie 6v¢nts were a¢rt)ss a wide lange of subjects, and across a variety of audienc65. including studeiits and trainees. ilal Ediicalio ic Educalioii Teani {slaff aijd voluiiteers), via a sys¢ein of siib-editoJ%. eIisure that the wcbsite is up to date. Tht Comniittee has appmved a numbci. of iiew case i'eports and haetnatology in)ag&8 for piiblicatÈon on the site. Tlie Committee has also WTitten a tiurnbei'of Multiple Choic¢ Qu¢stiolls bascd ot) recently publisljed BSH guidelines a#d good pi'actice papers which have been added to tlie question bank on the website. Th¢ review of all educational material published is ollgoing. The Society invc8tmellt in the Leai'ning Manageinent Systtm (LMS) had been pos¢poned ili 2022 due to Staffing and technivdl Trssues. The first course oti ti'aiisfusioii, designed by volunteer5 on tlie Education Committee, is due Èo go live in late 2024. Rcgi51¢red company Mil￿]ber., 02643706

The Bi'itlslk SocLEt)' foi. l-IHcinAtology (Limitèd by guai'a]Eteel Trllstecs, i'epoi't 9￿a eort*)liilRteil fina￿(1￿] $t2ttiiients Year ended JO Septembej. 2023 Gi'Ant5 AwArds prizes ie categories of awaYd5 aTe as follows.. GrHnt TotAI Av8il8hle Mf¢X era lieallt Studeiit Elective S¢holaTsIii Travel S¢holai%hi Aiii¢ri¢an Society of Hem&tology Tjavel Schol￿shi Pool of £20 000 8 awards er anniim er annui axiM￿rn £l,OQO maxi1￿lIM £1,000 ei'a licant licant tj'a 3 awards er anttEim maxiiniim $3 000 el'a licant Eiii'opean Heiiiatology Associatio TTavEI Scliolaishi Earl -sta e Reseai'eh Start- BSII LiSh4 Travel and Abstii Scholai'shi Mceti It rants Visitin Fcllnw.%cliDlaixlii rraincc Educatioti Biir%arie5 Global H&cl￿at0[0 £cholarshi 10 awards ei. aiiiiu er ajilluin maxijnuni £500 maxirniim £40 00 el'a rants er li¢fjnt Poal of £63,750 available 5 awards El. annii l award er aniiuiy] Pool of £IU,OUO &vailgbl¢ ei. ear maxinium £1 000 m#xiJnuin £1 000 maxijniiin £18 000 rvlaximuim £300 Inaximum £6 000 lirant Up to £50,000 per year to a total of £150,000 per proj¢cl ovei. the ci)iiixe af thTee eaTS era licant erd er£1 lir¥nt i. a Cohort Stiid Gi'ant * BSH F¢llows it) Clinical At * l award 2 awards ei annul 10 £90,000 The funds for these awards Ait from Desigiiated FU￿dS Furtlier iiifomiation on ihe grants progyamme is available on the BSH website. The Research and Grants Committe¢ oveives tlie ￿￿ttt applicatiolls tliat are not part of the designdted fviid. makes the awards, atld reports back iEgylarly to the Trustee Board. The BoaTd sets the grant-making sts?tegy tor the Society. (See also ihe SeCt￿Oi1 on DesÈ8nated Funds, with reference to the Data Rcgistry Pund). Last Ye￿ the Board designated £150k to assist thE Covid VaceiiiatÈon Funding Collaborative led by BIoDd Cancel. UK. The prujec¢ cai'i'ied uut research into efficacy of covid vac¢ine for people with blood cancer and dui'illg the yea¥ the filial eonlmbution wos made to the PToject. Miis is repoj'ted iii Nute 6. In 8eptembei' 2023 tlie Board designated fvnds to support two BSH fellows to work, part tinje, foi. a year oj Al projects specifscally aligned with cliiii¢&l haematology. At the end of the yeai. £101.995 worth of scienlific gyants had been awarded compared with £79,619 in 2022 (see Note 61. A total of 76 giants were awarded eompared with 42 in 2022. With travel Yeslriclions beillg eascd now, Jnor¢ travel- related g¥attts were ablt to be awarded, includinR tnore SuP￿rt towards Global 14aeiiiatology. Dul'iiig tlie yeai. the Eai"ly" Stag¢ ResEaTGh ILSIII awards wei'e iEviewed after having becn put oil hold,. IliE figure disclosed in note 6 represent5 refvijd of bolance of gi?nt unu5¢d (2023) and ali iiiider-payment adjiistmellt (2022). BSH ¢ontinued witli the National Itistilute forHealtb Research INIlIti)- BSH"Researcli¢r ofthe Yea¢, awai'ds iujd three 3waTd5 weye Lnade this yeai. which were presented at the Pirsidcntial sessioji at the ASM. BSH also awaTd¢d cash pi'izes to the top two entries in its annual 5tudetit essay comp¢Éition to a total value of £750. Regisleird company nuinbcr.. 02645706

Tlie Britislb SDciety for H%riiiMlology11.imiled b), guira￿teel Yeni. eiidcd 30 Septenibcr2013 Clinical G￿ldelineS The &)ciety'5 Guideliiies Cottiinittee and its foui'T3sk Forces cojitiiiued to pyodiice liigli quality clinical guidelines wliieli not only 8UPPOlt she haematological conimuiiity in the UK biit are used worldwide. Tlie Guideltnes Committee h88 also provided haesllatological advie¢ to tl)e Nafional Institute for 14ealth and Clinical Ex¢ellen¢¢ INICEI. The Giiidelines Committee recriiited foiiv traijiees, on¢ for each tAsk force. 'fhe trainecs have a one year telllll'e and will be meiitoi'ed by a task force meinbeL'. 'fhey will participate in dll thetask foi'cc tasks, IrvieW￿g guidelines, pivposals and paiticipatiiig in guidelines wiiting groiips. Thi5 lias been highly 5u¢c¢ssful, Jnd th¢ Society will be reci'LIEting the ncxt set of traillces in Januaiy 2024. The costofthe pl￿dUCtion ofguidelines was £23,138. which included £16.695 spenton liletature searche$12022.. £25,394) and £6,443 spent on IEcoiling of audio tominentai'ies. The &)ci¢ty has continued to piDdiice Good PtactlEE Papei's and PDSjtion Papus iii additioTJ lo tlie hll Guidelints. The SocEety published its first Position Paper iij Jaiiuary 2020. Red blood cell specificatiotis for yatients witli Iiatmoglobinopathies. & syste411aii¢ i-eview and guideliiie" The Society PTodii¢ed seven GuidelÈnes, foiiy Good Pi?clicc Paper{GPPs}, and one Position Paper dui'ing thc year. Many of the recently publisli¥d giiEdelines liavc a written ¢ominentary {published in the BJllaeipi) and aiidio comn)cntary {pod¢￿tS). Link5 to tli¢ Judio ¢ommentsries are available fjn the BSH web%ite &nd on PodBean. From Jail￿al'Y 2021 the audio cornmentaries are available to download. 1Mc Gu*delÈIi¢s. GPPS and addenda issued durittg the year were.. GenEI'al Haem Task Force Good Pi?GtiGe Pdper (In Ihe Use of next-geJi¢i?tion sequ¢n¢ing in the diagnosis of congeiiital anaen]ias joint giiidelijie with EHA and joii)t publishing in Iljll and IltmaSpheiE PubliEhed 6 June 2022 2. Guidelilles on the l.ahi¥ratovy Diagnosis of Malaria (Published 10 Mairh 2022) (audit wrillell) Guidclines for the monitoring and managemeE]t of ilDn overload in patients with haemoglobinopathies and rare anaeittias (Pyblished 6 Ocl 20211 {audit wi'iltenl (Podcast piiblished) 4. Guidelines on the diagnosis and ijrafmtnt L)fddult dplas(ic dn&einid (subinitted for publishing 6 Aug 221 Guide[￿eS on th¢ SignifiLant haenioglobillopathies.. guidelines toi. s¢reening and diagnosi8 published IY April 23 6. Guidelines on the MaDagemetJt of Conception and Prrgnaii¢y in Th&las￿e￿ia Syndromes 7. Guideline Diagnosi5 and maiiagement of inyelofibrosis publisli¢d Nov 23 Haem-onc Task Foir6 Good Practice Paper.. Recommendatians for Laboratory Ée5tang of patients with Acute Myeloid Leukaemia in the UK (Published 27 Oct 221 2. Good Prarti¢e Paper.. Manageinellt of 5Econdaiy CNS lymphojna {SCNSL) ) publislied 28 Nov 2022 3. Good Practice Paper.. Invesli£ation atid N1￿1agemeftt of the Mono¢lonal Ganimopathy of U1)deter￿lI}ed Sigiiif%cancc IMGUS) Publishcd 19 May 2023 Gutdelines on Diagnosis and Maiiagerllet)t of MaIiagetnenl of Mai)tl¢ Cell lymphoma (Publislied 30 Oct 2023) 5. Guidtlin¢s'. Diagnosis and iiianagement of I￿ar&Inal zone lymphoma (Published Nov 231 Rcgis1¢￿d conipaiiy niilliber.. 02645706

Thi. Bi'it15h Sociely foi. HaemAtoloEY (Liniited by g￿￿ya￿te¢) 'rru8tees' iypoyl and ooiisvlidxted fJnAnclAI 8tAttlMellts Yexi. emded 30 Septenibei. 2013 H&T I'8sk Force Guideline on Atticoagulant Managetncnt of Mechanical Heart Valves in Pregllancy IPiibli5hed I l Api'il 23) 2. Positioii Pap¢i' Joint giiidaiice froni tliE British Societies of Inteiveiitional RadEology a]id HaeEiiatology oil rnanaging Bleeding Risk diiring Proceduirs in Interventional Radiology {Piiblislied 31 Jaii 20231 3. Guideline on Diagiiosis and inatiageinent of tliroinbocylopeni¢ purpiira and other thromboti¢ microangiop&thies (Published 13 Aiigusl 2023) Ti?nsftrsion Task Force Guidelines on the investigation and mailagement of Acute TransfusioTr Reaotion5 (P￿blis￿led 26 April 23) Guidtlitieg oij the Specficatiott and use of iiifomiation technology {ITI systejiis in blood traiigfusion pi'actTce {io br subtnitted for publisliing to Transfusion joui'nall 3. GuideliThes otl IdentifiLation and maiiageinEttt of pre-operative anaemia {submitted 19 Nov 231 The Guidelin¢5 Task Forces have &lso collaborated with the Education Comjnittee, which lias wiYtEen MCQS for the followiiig guidtlijies.. Guidelines on the tsse oi. ii'radiated blood eompon¢nts13 questioiis) Management of cardiovasciilar complicaÉiolls of Bruton tyrosine kinase inhibitors {2 questioiisl Tli¢ niasiagement of CRStleinaii disease {2 questions) Guidelines for diagnosis and mai)agement of liaiiy cell leukaemia IHCLI and hail. cell val'iant IHCL-V)11 question) GuidelEncs foi. the diagi)osis and evaluation of pro￿lOSIS of adult ￿￿Ye]￿dY￿p1ast1L byndromes12 questions) Frolltline Jllallagemejit of post-transplantation lymphopiDlilerative disol￿¢1' in adult solid orRan rLLipi¥nl patients16 qu¢stions) The So¢i¢ty, as parl of ils strategy. has illaiiitairted the guidelints programme budget for literature searclies- and the budget for other 5¢1ViCC5 PLDvided by m¢diGal WTlt¢rs. Membei'5hip The long.teiYll impa¢t of the cost-of-liying crisi5 and workforc65 issues al'e not yet kno￿). Wliilsl nien)ber numbers are still increasillg ycar on year, the Society is not comp12cent. There w¢r¢ 2,930 AGtiv£ [ne￿berS at tlie year-eLd wljidi repi-esents a net illci'ease of17 from the previoiis year12,913). Co]nmunieatlons Oui. IEach via social Incdia, e-bulleti￿S and our website continue to grow. Our most popular social media channel is X (formerly known 8$ Twitter) wh*ch has gi'own froin 14,032 followei's last year to 15,124. All our social media a¢¢ounts have engagemeht from both haematology pvofessionals and patients fi￿￿ around the world. BSH ha5 a of e- biilletins that mtihb¢rs and non.memb¢rs can sign up to, the most populai., at the time of writiiig. beTng'. Guidelines 7,407 5ub5¢1'ibcrs Events 5,972 511b501.ibei Grants 5.165 subscribers Meniber-only 2,420 subscribers R¢gist¢red ¢ompany number., 02645706

rhe Byitisli Society foi. H#tllialolTrgy (Liniitcd by gu¥i'2iite¢l TJ'u5tees' J'cport con$olidxteil fE#aneial $tiii¢nitrtts Yexi. ended 30 septe￿be1. 2023 Oiir op￿1 i'at¢5 avei'age, at 51.5Yo, which is well above the iiidusti'y avei'age {26.3.Y.l. With Google AnalytlGs bcconiing obsolete in July 2023, the Society switched to GA4 foi. tracking website views; GA4 Irporled 192,561 views, of wliich 53,256 wei'e f(kr the Gu(delines page. showing that, as ill pi'evious yeaTS, the GuEdelit]e5 ￿Main tlie niost 115cd wtbsite resoulres. The Society's CMS ceased to be suppojted in Scptttnb¢i' 2023, n¢¢¢ssitating essential and extensive iipgi?des to the website. Iii ord¢i. for tlie So¢iety to host Inore educational videos. the hosting GapaGity wa5 iiicreastd. Advocacy Thc 2019 BSH Woi'kfor¢¢ Report, pliis the 2020 membership sujvey highlighted the inciEased pressuj'es ihe etitire haematology workfoT¢¢ and workfoj'ce issues weir se6n as a major concei'n fot the ITaemb¢rship. BSH. aftei a t¢nder process, appointed Loiidon Soutli Bank Uttiversity, in a groiip headed by Prof. Alisoii Leary and Dr. Adele Stewarf-Loixl, to look at three areas of the baetnatology workforce-. Workfoire gap analysis Pr8Ctitioner wellbeing Identifi￿tiOn of solutions alld impTovernent5 As of Deceinber 2023. desk Yeseaych has been coinpleted and tli¢ SoBi¢ty 15 ourrently ¢olle¢tiiig data via a In¢mbei3hip wide suj'vey and R census of all Iia¢n)atology departmellts to feed into tliis woi'k. This project is due to be tompleted by August 2024. BSH advocate for tl)eii' membei3hip via.. Working wÈlli other organisations, for example: o Cojitiiiuiiigto siipportwoi'k by tlie RCP on theiy two canipaigns'strengtli ill nurnbers" aiid'liiwualities n Healtli AllÉance" Respond to th¢ Siekle Cell Society con5111txliun'. Sickle Cell Ni11￿.1￿¥ Woi.kfvire Lullfvr evidence Repirs¢nlaliun at reltvant stakelioldei. meetings. such as thc RCPath Woi'kfo¥¢e workshop {Oclob¢r 20231. Engaging with p&rli&iiiEtElai'y group5 siIGh as sponsoying the ￿PC oji Diversity atid Inclusion in STEM Elld att¢i)ding APPG on Sickle Cell and APPG oll blood Caiicer meetings R¢spondill8 lo g0velT￿ettt oonsullations, such as Department of Healtli and Social Care.. NHSPension Scheine.. pi'oposed L7nieTrKlment5 lo BcheFNe iegulaliov aitdihe Cancel, In￿0}1￿110￿ Inqiiijy (Api'i12023) FinAJJee Tlie Board ¢ontinu¢ to IEview liow i))oi'e of tlie ttserves snigljt be used for pi'ojects ill ￿rther2￿ce of tlie Society's charitable aims and objeGlives. liifected Blood Inquiry (IB The Society coiitinucs to assist tlie JBI which is now IEviewing tlie inaterial tllat tht Socicty released to it in eai'ly 2019. The Offieers and CEO have delegatcd authority frorn the Board to handle the queries raised by the IBI as and Whe￿ they I'j5¢. Registe￿￿ ¢oJnpany Duin&r.' 02645706

The Brit15h SocÉety fur Haelliatulogy {LiJnit￿l by guarantee) Tvv$t¢e$' i'EPDI't n(I coiis01iilxteil finnnciRI 5thtetneDt5 YcRr ellded 30 Seplcmher 2023 Revi•v rftFlSrteiioiis rtii¢l osilloii Tlje Tyiistees al'e satisfied will) tlie group's I'esulis for tlie year whicli are sliowii in tl)¢ coiisolidated stateinent of fiiianeial activitit% and income and expellditure accountoii pag6 19. 'fhe Society has inciirred lio financi&l costs in amy fund12ising activity- Neither did the Society engage aiiy extel￿al fundrai5¢15, nor did it receive any complaints IEI respect of 11$ futtdraising activities. The FiiiaDC¢. Aiidit and Risk Comrnittec {FARCI i￿oni¢0r$ 811 finaiicial asp¢cts of the Society including ils trading a¥i and tlie investments sti'ategy and perfomaiice. Intome Thc total c011501idated income for the yeai" was £2,840,236 (2022.. £2,606,810). The bÈggest iiieome slreain Temaiiis the shaTe of the PTofits of ihe Bi'rlisJ3 Joiiii?al of Hael1￿1010￿V (both BJHI￿ni eJHaffDIl which was £1,093,57312022-. £1,144,431). Durillg the year, the impact factor of the SJllaein was 8.615. it ¢on¢tnues Éo appear ttj the tap qLiartile of haematology jounials. The eJHtteipJ is now in its tliird year and continues to grow, with l'oyalties of £77,119 b¢ing paid to the Charity in the year, in relation lo the Jouimal year ended De¢ember2022. Th¢ Society continues to moiistOT the Jounial fiiiances aiid the forecast for thi5 year iETllaiiis eonseivative. Th6 surxess of the FAC¢ to Face ASM in April 2023 produced £1,363,672 of total in¢ome. Income frotll inembership subscriptions was £243.874 (2022.. £233.8681. with an incr¢a5e itt subscription l'ates being in)plemented in Janusiy 2023. I'here weTe 2,930 artive members at the year-end which repirsents a iiet increase of l7 frtsin th¢ previous year {2,9131. Inve5tm¢ttt in¢ome was £139,08212022.' £52,465) reflecting the inci'ease in iiitei'est rates as well as the tiansf¢r of funds to the CCLA invt5ttntnls tx)I'ifulio. ￿v¢n that the profile of these itsvesiments dre perfotTniNg well in lh¢ bui'rent maTket. The miniinum iE8erves, as stated in the tnv¢5tmeiit Policy, have been i'etaiTh¢d within th¢ Coutts InvesttneTJt portfolio, which colltillues to maintsin 8 defensiv¢ stEZtegy. The Society shows divideiids iEinvested ill the Ikivestment Portfolio as income duriiig the ye8r that it was received. I xperidituie Most resoiirc¢s exyended weir for runiiiiig the So¢iely, ruttning of the annual confeirn¢e, educational S61VICeS providing the Journal to tn¢tnber5 aiid re5eaFch grant5. GTallls air ￿￿OgnIsEd iii the Statementof Fii]allcial Activities when they are authoi'ised by theRe5eai'ch and Gi?nts CoJnmitte6. See &bove. SignificantAGlivities andNotes to the accouiils foi'detailed repoiting on gi?nts and education as well as details on tht Enain stiraEllS of expendtttsre. The trading subsidiary iEsults are discu55ed btlow and at Not¢ 9. Design8ted Fund5 The work of thc Global Haematology SIG was i'eactivated having been postponed during 2021. The Plenaiy Speakers sclieme was reinstated May 2022 witli threc speakers sel¢fjt¢d tn speak at COT)ferencEs Egypt October 2022, Ghana in Noveinber 2022 and Tliailand iii May 2023. The Global Haematology Scholarship has four grant5 on offer, which wtre awarded. The SIG liad pi'eviously link¢d up with tli¢ ASH Sickle Ccll New-born SGretning Pl'ogi'amme and professiotials in Liixbia, and the individua15 llivolved rcillaiii in conlacl, with a visit to Zambia going ahead in Au8USt 2023. Regisiered ¢omp&#y number.. 02645706

Tbe Bi'itisli Socitty fni. Fl%¢ttialology (Limittd by gua1￿￿te¢l Ti'usttts, Jporl tonsolidAt￿l fiiitsncial slateiiients eRr L'nded 30 Sei)tenJber 2023 The Wilkinsoii Bequest ¢ontinu¢s to support the provision of the Sir John Da¢ie L￿tuly by an inteL'&IRtIDnal speakeT at the ASM in ¢onjiin¢lion with the RCPatli, Costs associated willi tliis lectiire iii 2023 aiiiouiiled to £144. Durin8 the yeai.: £22,398 has bccii conti'ibultd to the BCUK Vaccijie Collabar&tive. £40,519 hds been coii¢ributed towards Global HaeinatDlogy support A in8ximum of £90,000 has b¢et] set aside to siippoit two BSH fellows, p2rt time, for a yeai. on Al proj¢¢ts specifically aligntd with clinical haeinatology, with scope lo extend this fiiither after reviewing its succe5S. In 2020, the Board a150 designated £20k to be spent over two years on regional events aud ¢diiGalion. The fEind was duc to roll out dur2ng 2020 witli th¢ Reseawh and Grants Committee adininisteTing it. However, because of Covid-19 Iliis was placed on liold and 110 fuiids have been 5PBlIt. Ti'ldliig activltles The Cliarity's subsidiaiy coinpany made an overall profjt for tIiE yEar of £428,797 {2022.. £155,175) and Ihe results are shown ill note 9 to tile financ£al statejnellts. Reserves policy The a8SEts of the SoGEEty iIiGlud¢d tangibl¢ fixed assets £405,941, investm¢nts of £8,118.722, net cunEnt assets of £2,629,131 and ovEI?11 tlie Society's llet assets stand at £11,153,794. TIIIS inGlude5 desigiated fijllds of £387,542 and general funds of £10,766,252. During the ye￿. total fullds increased by £412,472 to £11,153,794. The FARC continues to tiionitor tbe Cliarity's Resei've Policy annually. Tlie level of tlje Operational ReseNe continues to cover 1.5 years of riinning Costs shoiild it be lleces5aiy to wind down the So¢i¢ty for gny vnantiGipat¢d rcaEon OT if future income falls- plus al￿0)￿￿tS lu ￿Ver fluLtudlin% ASM surpluses and the unlikely Ibiit if it o¢¢iirred, da]naging) drainatic. utt¢xpe¢ted105s of sponsoiEliip incoine for the ASM. An allowance of 200A foi. Tnarket volatility was agjted. resulting in au Operattonal Reserve fIgure of £2,550,000. In addition, tljere should be a cash irsei've of £500,000 at the year et]d lo maintain fluidity. please see the table below which 5how5 the short attd long-term operationAI reserves. Excluding operational fixed a5scts, operational irseives and designated funds. sui'plus res¢iYes at 30 Septe]nbei' 2023 afe £7in. Ihe Lloard regulayly propose desigiialed funds be 5¢t a5idB for pl￿jectS, in line with the Chai'ity's objectives, in ordet. to inakc use of thc Soctety's sui'plus Yescrves. SHORT I'ERM FUNDS Operational cash iEquirenTrents are ljeld in accounts with Loutts and IISBL, as aiE those for BSFI Ei)t¢ipri5es. Short-tertn r¢seiwes aiE hcld in J Coutts R¢s¢rv¢ atttsunt. Fund5 it] excess of cashflow i. ullrinents are eriodi¢all moved to ihe ii)vestn)ellt funds. £500k at th¢ year ejid LONG TERM FUNDS The Miniiiiutn Reserve is managed rts pai of Inyestnient Fiinds by Speciilt51 Investment Manager5 with sE)m¢ risk piDfile as funds I'eqiiired 3-5 yea¥s, £2,550.000 TOTAL £3.050,(tOO Regi$l¢red ¢oinp&ny nurnbei-. 02645706

The Bj'ltlslk Sotlety for Haem*loltsgy (Limited by guai'aiileol Ti'usttc$ i'epoi't And consolid%ted fi]kRncial stattmtiits Year eDd¢d 30 September 2023 Investmeijt policy Investn]¢nts GDntiiiue to be m2naged acu)rding to the Illvest￿cJt Policy agreed ill Jaijuary 2019. Dui'ing the year the Boai'd aiid FARC agi'eed to retain the ininimum r£s¢rve5 l¢v¢l withill tbe Coutts portfolio- & low risk, def¢nsiv¢ strategy and hold surplus funds within the'CCLA portfolio and COIF Deposit account in oTd¢r to maximise investment income during the cunrnt in8rkets. Thc ov6rall investtn¢nts m&rket value illcirased by £270,575 tn the year (2022.. £130,045 deerease). The portfolios are aimed at growth in value rather than in￿]ne generation, with incoine reinvest¢d. The tota] inv¢stmenl portfolio wa5 valued at £8,118,621 as at 30 September 2023, compared with £7,848,046 fft 2022. Investment inconie was £139,082,.compaKd with £52,465 in 2022, with dividends rerxived and b¢ing reinvested within the investment portfolio being shown as income in the year. The fund ￿allagerS aiE ddhei'ing to tlie restri¢tions iinJx)sed by t￿e Trustees regaTdillg et1￿Cal standards. The progi'ESS of the inve8trnmts is tracked aiid reviewed regularly. Th6 Trust¢¢s have taken advi￿ from the investment managers and have invested in a rauge of investments and managed funds which ineet their ￿vestMent ¢riteTia. Regulai. performaR¢¢ repoit5 arc rrceived, and the investment is reviewed on a regulai. basis by the FARC and by the Boa￿1. with bLltli CCLA and Co￿tE presenting PDrifuliu llpdates to thc FARC at its January meeting, The Coutts tnvestment fund is defensive. the CCLA is medium risk. Wliilst tlie Tivstees are not CO￿p1aCe11t, they are confident that the Society'8 substalltial reserves will be enough to see t￿e organisation through for tli¢ short & medium temi fuiure. It)vestmeMt powers TheTrustees havethe powtrto invest funds notimnjediately ￿qll]red foropcratiollalpurposes ill such concen￿, securities or PiY>PLW as thEy think fit. Pi'inclpil I'isl($ 8nd unC￿'taIntieS The Trustees as5C5scd the Society's risk registei. arnd the DirectoKs of BSH Entery)rises Lid assessed its i'isk registu. in Septembei. 2023. This exerGisv is undeitakeji on an AiittUa] basis In a¢¢ordan¢e with theguidelines for ¢hariti¢s. Following thB dSsessmenls, both docujnents wer¢ revised and iipdated. L'h¢'frust￿ of the Society and Dii'ector.s ofB,SHF.nt¢tprises Ltd b61ieve th¢y havetaken enough steps to initigatcthc risks idelllified foreach organisation. The principal iisks that the Society fac¢5, as id¢ntifi¢d in the updated risk register, are.. Failur¢ to tIBn%late sti'ategy illto achievable alld Measurable aotivitit Faslure to ¢nsur¢ thd the new 8ttvctures within BSFI woi'k togetlier effectively.. Major IT Systetns failuir including failure of exterll￿ suppliEI8. Potential fmA#¢ial losses, i]L Particular from trading sybsidiary du¢ to dr(¥p in revenue from delegates at or Spollsoiship of the ASNI. Below. we highliglit the mitigation work to these risks. The Society is follDwing its cui'rent strategi¢ objectives- supp)rtiDg meinbers,. knowledge tt%i)sfer and advocacy- with The Board I'eceiving updates on the progress of the 5trat¢gy twi¢¢ a year, so it ran monitor effectively. The fociLS on advocacy with aparti¢ular focus on work foi'¢¢ is a new aira forBSH and much of its efforts are on building solid foundations in ord¢rto betteT SlSPPOrtthe haematology work farce. A in&jor pl￿jCCt on workfoycc is GU2Tently undei. way. as noted in the Desi£nat¢d Fund Note 18. The Society is focusEd ellguring that struGtwr (th¢ two Boards, Committees and SIG$) and resources (staff, building and monryl are used optiiiiajly to ensure that tlie 5tixtegiG pldll will be Rrhirvable and will eiihttfi¢e the ¢harity's aains and objE¢tives. The Society offLCe tcam is now working a bybrid officethome format. Registered company nullib¢r'. 02645706

riEe British Soci¢ty for HRcniatology ILimiéÈd by guai'anl¢t) Ti'iiste¢s repoi't Ajjd ￿nS￿lI￿A¢¢I7 rtn211eig1 staltni¢nts Yelli. eRdÈd 30 SÈpt¢]nbei' 2023 BSH continues to woi'k witli its professional IT support conip8riy to maintain and impiDve its Icr Infi￿t￿lO￿lLe to ensure optimal woi"kiTrg effi¢i¢ney and robustness. The SoGi¢ty continues to ]nonitOT and review its Disastei. iiecov¢ry Plan, witli a particulai. focus on IT systems failures. The charity reinains a necessBry source of ¢du¢alion and support for the haematology profession dnd Imaterial losses in IneinbtiE' subscriptions are not ￿tI¢1pated following the pai)demic. The levels of subscriptions received in ]￿]￿alY 2023 wei'e consistent with lev¢15 in previous yeHrs, and there have not been substalltial callcellation5 and requests foi. refunds during the pandEIIiIC. John Wiley & Sons regularly update the Society OD the ftnances of the Journals. The 2023 ASM was a face-fo-face meeting in Bimiinghatll, witli encouraging Gornmercial suppoit and registrations generating ￿ overall sub5idiaiy piY)fit of £428,797. VAT The Society Continues to monitor its VAT status with the assistanct of its advisers aDd managem¢iit acCO￿￿tant. Slriiclure ov￿.￿&/[cE &iid The chartty is an incorporated legal entity limited by guarafttE¢, the business of which is governedby aBoard ofTrustees, which meets quarterly. The charity has 16 FTE staff in¢iiib¢i's' this nuinber includes some temporary staff at)d it i8 the Society's plan, wh¢r¢ appl￿pIlate. to ttiake these rolss pcrmaiiciit in the next year. Th¢ Tru5tecs have delegated day to day ￿spOnSIbIlIty for thc iunnillg of tkne charity to the Chief Executive. ciallnlei-esl GFOZI ondothei. Yov The Socety's six SIGS.. Global Haematology. Laboiatory,. Lymphom4 Ob5ttts'ic8,' PaedÈatrc", and TeeDage and Young Adults (TYAI are all J¢tive lll th¢ir area, uTrdertaking cducational WOTk in various ways. The Society also has an Eg1"ly Careers Foruni whiGh 15 makillg exccllEllt progress OIL the piloting of a m¢ntoi'ing scliune. ThB designated Regional Events Fund, which replaced the regional lead stwcture, has been on bold i￿t the Board will ieview tIEis in 2024. The ¢harity ha5 invested £2 in a wholly owned tsading subsidiary BSH Enteiprises Limited IBSHE) through whi¢li the Organisat￿On of the Alluual Scientiftc Meeting {ASM) tor th¢ Bi'itish Society for Haematology is condu¢ted. The coinpqny, BSHE Ltd, gift aids ils taxable profits to the ¢harity. The Ti'ustees of the ch81.ity and the DELECt0￿ of the subsidiary are responsible for strategic diirdion and govemance of the BSH and BSHE Ltd. The Key Management Personnel of the group compi'ises the Th￿teeS IDirectoiE aiid the CEO. No Trustees wei'e remunerated during tlje ye&i' {2022'. iiill. Total i'emune]Trtion to the IC¢y Maiiageinent Pet￿nn¢1 wa5 £73.85312022.. £74,144). The pay of tlieKey Matjagement Personnel IE reviewtd annually. In view of the nature of the charity, the Trust¢¢s b¢n¢hinark against pay Irvels in othti. Ch￿'Ities. The iEnuneration sctting policy IS tbE mid-point of the range paid for similar rol¢g in similar-sized charities. Appointment of Irustees/dii-¢ctors Elected Truste¢slDiiicloi's are appointed by seGret ballot ofeligible members duiiiig Febrnai'y-morrh cach year., Ordinary Ti'ustEe5, the SEoTetsry and theTiEasurei' 51t forathiEe-yearterin and the Vict-Presidellt seiv¢s twoyears before becotning President and serving a fvrther two years. OrdKnary Tru5Éees, tli¢ Secretary and Trea5uiEI' may stand foi. election for second three-year term, thei'eby eJJabling them to s¢rve up to six years on the Board ui this role. Following a General Meeting iji Septembei. 2020, Trust¢¢s now tal(e uplrelinquish office at end of the Ansiuftl Succcssion Board Meeting, pj'eviously tliis oc¢uri"ed at tlie Trustees, Meeting lieId dw'ing the ASM. Thi5 ainendinent aJlow5 the B0￿d to appoint Iiew Tru5t¢es ¢ven if the ASM Es cancellcd oi. postpond in fulure years. ReBtsl¢red conipany nuinkr.. 02645?06

The British Sooiety for HfienJAlology (Limited by 8U2rll￿teeI Ti'ustcts, i*poJ't and cortSDlidattd finiifftel41 $talÈm¢nt$ YeRr ended 30 Seplembei. 2023 The Boai'd has the power to co-opt up to four Lay TrusteE5, Ihc5eposts hav6 tx)w bren filled, broadening th¢ experti5¢ available to tlie Boaid. The Society provides new Twstees with an iiidiiction and guidance from the Charities Commission and otiier relevant publtcations. Trustecs, retnuiiei'atioii and expenses ait detailed in iiote I I to tlle fitianeial slateinents. Politi￿1 and chai'itable Contrib￿tionS The WLTP ¢anllotinake polttical tonlributions iindei. their govetllinE dooumenls and chaiity law. Tlie group has iiot niadt any cliaritable donations during the yeai. Fiihire PIGA5 strRtegic Dii'ectio The three eurirjit sti?tegic aims are.. suppoitiiig Iiiettibersliip atjd tlie wider pl￿feSSIon., education and learning. and advocacy for both the PTofessioi) ai)d the discipline of haemafology. The So¢iety will work towaiY]s laujiching a llew strat¢gÉL plan in J¥nuary 2024. This will build On tlTr¢ exLellent foiindatiuns of current aims diid plans and in particulai., will fuither develop our WOTk on advocacy for tlic haetnatology workforce a]id tsiit digital leamiiw otTeiing. We will ieview the cojicept of furthcr partnerships with the biomedical and phanna¢eiiti¢al industry e.g. via annual sponsorship. The So¢iety will take due tvnbidEI?tivn ufili¥ likely tnediunj to IollR-lemi consequeiices of Covid-19, economic and other major external finatkcial and geo-ptrliti¢al fa¢toi's 01) BSH overthe lif¢time of the new sts?tegic plan. GoYern8nee infrAsti'uctui'e The So¢iety has I'e¢ruited four Lay Tnistees with skills and expeTience in gov¢i'iiance, 5trategsc planning. EDI and 5118talliability. 11 has also appointed two extEmal B Dij'ectors tts the tradiiig subsidiary, BSHE. The Society coiitinues to woA( on ensuring that all its constituent parts: Boai'(ts, Committees, SItis and staff, are working togetlier and followi￿8 the orgai)isatiot)'s straÉegie direction. During the year tlie Head of Operatiotts has unpl￿ved the internal processes. policies ai)d gokv61'llance. Tbree new poliGies have been wi'itten, and 12 have been updat¢d. Tlieie 18 also now a foirnalised process and titnetable for updating all policies on a regular ba5i5. A foiThalis¢d induGtion for all Trustecs and voliinleers has also been developed. An external Dat8 Protection serviees pl￿vIder has been appoiiited (Hope and May). and WorkN¢st, our ext¢itEal HR on5ultJnts, have been appoiiited to pl￿VIde a full Flli sei'vict. wl)ich will iit)prove HR suppoil to staff attd ensure better document Control. Tliese impiDvenieiJts will help the SocieÉy build a Jnoir i'obu5t infi?stnLcthre by ensui'iiig good working practices across all oui. acliviiies. Fin#nee The BoAI"d co￿1]nUe to consider the future iise of surplus reserves and sct aside Designated Fuiids for specific pui'poscs. Details of thes¢ fund5 are iii not¢ 18 to tlie accounts. The Tiustees are aware of potential fluctuations in incoine skn'eains, but are confident tliat. givell the c105e tnonitoring of performance tn tljese area4 tlie level income will bc maintained over the short tts mediuni term. Re81slered company numbBr.' 02645706

Thc BJ'itl51I SDciety for H3O￿tal&l0￿ (Linjiled by guarantee I'rvstees, i'epoL'I xnd con501id2ted fJnlliJeio1 st#tenJ¢Jits Yeai- endea 30 S¢pteinber 2023 Despite the Covid-19 pande]￿[C aiid otlier ecolloilliG shocks in tlie global market. the jourllals have coiitiniied lo dD Very well fjnancially. Like niany othei. cornpatiies, thejournals publishers, Wilcys continue5 to ass¢5s scenarios as the global situatton evolves in Dirfer to bt pi'eparcd to adapt qiiickly. Sholild tl)e Society's incoitte drop siibstantially ihroiigh this pei'iod it has th¢ reserves to suppoit costs going foi'ward for 1.5 years and is ultimately in control of many of ihe Jiialerial costs. ASM At the lime of wiiling the 2024 1))ectiIig will go ahead as a fac¢-to-face event, takiiig place iii Liv¢]yool between 28-30 April. The FIDgrnipTrme Comiiiiltee, the BSH TTUStees, BSHE DiiEctors and sei)ioi' staff are plaiining fiitui'e ASMS 011 3 rolling cycle (cun'ently tlirougl) to 2025, with planning aboui to b¢gin for 2026) in order to secui'e attractive veniies al)le to aGCOlVtmodate an expanding ASM, wliilsl maijitaitiing a close view of tlie It)ediiim to long-tCLm effects of tlie Cov￿. 19 pandemic and other recent ¢con01￿le aiid geo-politi¢al factors. Membei'ship Our mernbership contiiiiies lo grow, especially tlie Asso¢iate Inember5hip Gategoiy, willi tnore nutses joining the Society and bei112 actively eiiRaged in ils goverjiaijce witl) representation on most of oui'committees. BSH will ¢ontiiiu¢ to Lnvest in tlie menlbership pa¢kage with a locus on improving the btncfjls including educatton iEsources, as well as advocacy work and rtvicwing Qui. gi?nts progrnI￿Me. 12 Regi$lered company numbei.: 02645706

SliilÉJiieiil o Trtlslees les Illlies iii res ecÉo Ilié Thi￿£¢5, Ré i'l ojicl copisolidtslcd IiiÉEiicittJslalenieiits The Trustees (who are also Directoi3 of The Bi'ilish Society foi. Ha¢m&tology for the purposes of coinpany law) a responsible for prepai'ing the Trustees. ReJx>it and tli¢ fillaiicial statements in a¢¢ordaiice with appli¢able law 8nd Uiiiled KingdoiM Accoiiiititig Standards (United Kingdoin GeRerally Accepted Accoiillttng Practice). Company law TeouirBS the Trustees to prepair fiiiancial stslemcnts for eacli fjnancial yearwliich give a twe and fair view of tlie state of affarrs ofthe chai'ilable ¢ompany and th¢ and of the incomiiig resources and applic&lioJi of IEsources, including the illcoJtTre and expenditui'e, of tbe cliarÉtable group foi. that pci'iod. ltt preparrng tl)ese fiiiancial stateinenls, the Tiuste¢5 al'e ￿qUired tD'. Sel¢ct suEtable accountiTrg policies alld then apply them collsistently. Observe the metliods and prÉnciples in the Chai'ities SORP. Make judgcinetits and estimates that are I'easoiiable and piud¢nt,' State wlietlier applicabl¢ UK AccottiJtin¥ Standards have been followed, subj¢cl to any iiiatei'ial departures disclosed and explained ii) the finan¢iAI statejneiits,. Prepare Ille fiiianctal statements on the goEng concein ba8is uiiless it i5 Fnappropriatc to piEsuinE that the charitable compaiiy will ¢oJ]tinue iji business. The'fiuslees ave ie5ponsiblc foj. keeping protKr accauijtiiig IE¢OTds that disclos6 NvÈtli reasonable accuracy at any tiine of the fJnAn¢ial positiotj of the charitable coinpany and ￿1}Up aiid enabl¥ them to ensure tliat tlie fillanci81 statements comply with the Coillpan2es Act 2006. Tliey ai'e also vespoiisible for safeguardii)£ the assets of the cliayitable cosiipaiiy and the groisp and hence foi'takTng reasonable steps for the pjrvention and delectEon ot'li'uud and other irregiilai'ities. The TTUStees re irsponsTrble for thc mainleJian¢¢ and integrily of the COfPOTatc and fiiiancial infoi'motion incliided on tlie charitable compatTry's websitt. Legislalion in the United Icingdoin govcrning the prepai'alioll and di55eminattoii of finaiici&l slateinents may dÈffer fix)ni l¢gislation iii other jvi'isdifjtions. In 50 faT as we are 8wai'e'. Thei"e is no irlevant audit inforillation of which tb< charitable eDmpany aiid group'5 auditor is unaw#re- and The Trustees liave taken all steps that they ought to have t4ken to make themselves aware of any Tclevanl alldit infoTmation and to establish that tli¢ auditor 15 awaiE of that information. Registered cnmpaiiy number.. 02645706

Tli¢ Britisli S&ciety for HicmAtology II.iniitcd by giEArRntt¢} Ye8r en(IcJ JO Septe￿ibel. 2023 erÉnce udtrJiiJilsli'ÉElion iii Tlie British Society for Haematology was regÉstered with the Ch&rity ComEni55ion ott 7 Novembei. 1991 (registered niimber 1005735) and was incoi'poTated as a comp&lly limited by guaixntee (reglsteird tompai)y number 2645706) on 13 Septcinbei'1991. The ¢ompany is goveTii¢d by its Articles of Association incorporated oh 13 Septeii)ber 1991 and whi were last updated on 23 lun¢ 2023. TruStee￿directorS The Trusl¢eslDitEctors w￿0 held office during th¢ year were as follow5.' Icei's President Vice Pirsident Th'easiirer Secretaiy Secretary Josh Wright Dr S￿¢ Pavoi'd Dr John Ashcl￿ft * Dr Jim Seal¢ (to 25 Api'il 2a23} Profesg)r Guy Pratt (froin 25 Api'il 20231 Oi'dinui. Di. Humayuii Ahmad Dr Subarna Chskr&vorty Dr Kate Cwyiiarski Mv M&i'k Ethell Dr Miiyali Kesavan Dr l iona Miall Mi. Huw Rowswell * Professor Johh Sttowdeji Dr Cathy Burtun 's Laui2 Miller Dr Shankai'anarayalla Patt¢esha (resigned 25 April 2023) {r¢signed 25 April 20231 (resigned 23 Fcbruary 2023} (from 25 Api'il 2023) (from 25 Api'il 2023) {fr(>m 25 Api'il 2023) c)-opledL TiiL¥lees.' Kate Fielding Mr Keith Wai'd * Dr'fhai'ittdi HapiiaiBchchi * Patrick ICeef¢ (from 25 April 2023) Ifrom 25 April 2023) * Membei. of Finance Audit and Risk Commiltee (FAJiC} At the end of 2023 the CEO left the BSH employment and th6 Stnior Leadership Team ctintntly covu's responsibilÈtLes until the n¢wly appointed CF.0 starts at the b¢ginnin8 of Aprs12024 ie Ti'u5tees of the charity cotkstitule Directors foi. tlje piirposes of tl?e Coinpanies Act 2006. R¢Eisteird conipaiiy number.. 02645706

Tho Bi'itl$li Soeicty for HTreniRtology ILirnited by guAraiitee) Triistees, repnj'l cotisolidatod finaneiRI stattiii¢nts YeAI' ended 30 S¢pttrmbei' 2023 Registered offjte.. 100 Wiite Lioli Street Fiiisbury London Nl 9PF Advisei'B The eoinpaThy's principal advisei's are as folloivs.. SolicÈton Bates Wells Bi?ithwait¢ 10 Queen Sti'eet Place LA)ndoii EC4R I BE Clayden Law I" I,'IooT, 22840 B&nbiiry Road Oxford OX2 7B Y Auditors Haysma¢intyiE LLP 10 Que¥Tr Street Place London LL4K IAG Bflnkers Coiitls & Co 440 Th¢ Strdnd Londoii WC2R OQS Investmeiit Advisci Church, Charity and Local Authority ICCI,Al Fuud Manag¢i¥ Limiied Scttator Housc, 85 Queen Vi¢tor%a st￿¢¢ London EC4V 4ET Coutts & Co 440 The Sti?nd Londo• WC2R OQS Audttors Hay5]naciiityJE LLP Iiave indicated their w¥llingness to be irappointed foi. another term alld apPl￿p1.1ate arimngeinents have been put in place for tiiem to be reappoiiitcd as auditors. In prepavizjg this rei)ort, tlie Trustees have taken advantage of d)e siiiall tompaiiies, exeniptions pix>vided by seetion 415A of the Companies Act 2006, By order of the Board Jn Asli J'easuTer IIK> White Lion Street Fitjsbllry London Nl 9PF us Date Regi$lered coinpany numbti.: 02645706

Tljt British Soeitty foi. HAcmR*olDgy IlJlltTriled by g1121'anleel Yeai. enijed 30 Septembei'2023 Independent ￿￿ditor'S i'eport to tlje niejnbers of The Britislj Society for H4em8tology (Limit¢d by guarantce} OpinioIi We have aiidited the finall¢ial statements ofThe Brit￿sh Society foi. Haematology foi. t￿E year ended 30 Septeniber 2023 wliÉcli comprise the Si&tetnent of Financial Activities, th¢ Balance Sheet, the Statemejit of Casli Flows, and Iiotes to the financial statenients, Èi)cliEdillg a Skiininai'y of sig]iifEcant accountiiig poltcies. The financial repoiting fra1￿¢Work that has been applied in tlieij. pirpai?tion is applicable law United Kingdom Accouiiling Standaids, iiicluding Finaiicsal Reporting Standard 102 The filllalyclrtl Repop'ling SiuJida3'd applicable INI ihé UR Repirblie of IIEland (United Kiiigdtsin G¢n¢i?Ily A¢¢¢pted Accounting Pra¢ti¢el. It) our opinion, the financi&l stat¢meiits.' give a ti'iie and taij. view of tlie state of tlie eliaritable eonip&ny's affaiJ% as at 30 S¢ptcJi)bcT 2023 aiid of tlie chai'itable cornpany's net Inovement Iii funds, Jrtcludi118 tlie incotne find eXp￿diture, foi. the year theti ended: have been piY)pei'ly prepared iii accordaiicc with Ujiited Kingdom Generally Accepted Accoujiling Practice; and have been prepared in accordance with the i'equirements of the Companies Act 2006. Basis foi. optnion We cottducttd ollr audit ￿￿) aetordance with Intei'iiatioxal Siandaiyls ott Aiidiling (UK) IISAS IINC)) aRd applicable law. Oiii- J'espojisibilities uiidei. those stalldai'¢L% are furtlier desci'ibed in the Auditor's iespoIisibtlities foi. the audit of tlie riiianGial statcment5 section of our irport. We ar¢ ind¢peJid¢nt of th¢ rhai'ity in accordance with the ethical i'eqttu'emejits tliat &i'e i'elevant to oui. audit of tile fU￿nCial slateiiient5 ill the UK. includiJJg the FRC'S Etliical Staiidai'd, and we have fuifjlled ow. othei. eihical Irspons£bililic5 in accordaiice with thes¢ requiirinents. We believe that the audit evidence we have obtained is sutTictellt at)d appropriate to pl￿vide a basis for our opinion. Collelusio￿3 I'elating to going eoneern It] aiiditing the fJnanGial stalt&nents, we liave concliTded tliat tlie ts'itstees, use of the going coiicem basis of aceoullting ill the prepai?tion of the financEal ststements is appToprÈate. Based on the work we liave perfomied, we have not identified any matei'ial uncetlainties relating to ¢venls oi. condEtions that, individually nr colltctively, may cast significant doubt on thc charitablt cttmpany'% dhility to cnntsnue as a going ¢oncem for a period of at least twelve months from when the financial statements are authori5ed foi issue. Oui. responsibilities and the responsibilities of the trustees with respect to goin8 concei'n are described in the iElevant seclioijs of this report. Other infni'tnRIi¥Jii Tlie tTilSttes are responsible for the otlier informatiot). The other infonnation cotnprise8 th¢ infortnation included in the Ttwstees, Ajinual Repoit, Our opinion on the fiiiancial stat¢m¢nt5 does not covti. the othej. ijiformation alld, except to the extent otherwise explicitly stated in our i'tport. we do not ¢xpress any form of assurance conclusion therwn. In contiectÈoii with our audit of the financial statement5, 0111. responsibility is to IEad the other infoiniation and, iii doing so, ¢onsider whether the other information is malei'ially inconsistent with the finanGial statetn¢nts or our knowledge obta￿lled iii the a￿di{ oi. otheiwise appears to be materially Imisstated. If we identify such mater%al iijcotisisteiicEes or appaiEnl matei'ial misstatements, we al'e lEqui￿d to d¢tcrrnin6 whethei. there is a material t21iSStateineiit itl the fitjancial statemejits or a material niis8tatement of thc otlie2' iiifoi'mation. If, based on the work we liave perfonxed, we ¢on¢ludr tliat tlierc is a Jnatei'ial misstatement of tliis other illformation, we are Yequii'ed to report that fact. We liave nothing to report in tliis regaid. Opiniorns on other m#ttetB prÈserlbÉd by the CompAtJles Aet 2006 Tn OUT opinion, bascd on th¢ work uiidertaken in the course of tlie audit.. ti)e inforjiialion given in tlie Triistee5' Annual Repojt (WE￿icI1 includes tlie strategic iepoit attd tlie diie¢toi's' report prepared for the purposes of company law) for ihe flnancial year for which the fJRaiiBsal statements al prepared is Consistent with the finallcial statenients; at)d tlie 8trate(kic report and Élle diTectots' i'epoil in¢liided witliin tlie Ti'ustees, Aniiual Repoit havc beeii prcpai'ed iii accorda￿Ce with applicable legal ￿qllI1￿m£nts, 16 Ilegisteted Lompany number 02645706

The Brili5b SoEicty for HacmatoloEY ILimited by gUA￿￿te¢l Y￿r ¢ridtil 30 SEPt¢mhi'r 2023 Matt¢i's on whith ive Are requii'ed to i'epoj't by exception In the light of the knowledge and uttderstathding of the charitable company al￿ its environment obtained an the eourse of the audit, w¢ have not identified n)aterial mis51atements in tlie Tnistee5' Anllual Repojt {which incorpoi'ates the stI￿legI¢ repoit ai)d the diirGtor5' lePOIt). We have noihinE to J'tport Ill irspect of the following matters in relation lo wlii¢li the Companies Act 2006 requires us to repoit to you it, in ovr opinion.. adeouate aGcounting Tecoids have not been kept by the chaiilable company. oi. the cliai'itable company fitiancial stateinenls are nol iii a￿¢eMent with tlie a¢wunting records and returns. oi. cei'ti11 disclosiiies of trustees, rei)iuiiuation speesfied by law are not inade- oi. we have not received all Ilie infor1￿￿tIOn and ¢xplaiiation5 we req￿lre foi, our audit. or the tTUStee5 Ivere not enliiled to prepare tlie fiijaiicial stateinents in aecoi'dance witli tlie siiiall cojiipanies, regiine at]d take advantage of the sm811 tompanies, exetilpttol￿ iij prep&rittg tlie liystees, report aijd fi'om tlie requiretJietJt to piepare a stratcgFC rwil. ResponsibilitKP5 of trustees foi- IIIE firtxntiAI stAtements As cxplaintd tnore fully iji the tsilstees, responsibilities stateniejit set out an page 13, Ihe tnigteeg (who are also the directoi's of the ch￿ttable COmPRny for the ptsryoses of coiiJpai)y lawl are Irsponsible foi. the piEpar&tion of the financial statements and for beiiEg satl8ficd that they give a irue and fail. view, and forsuch iiiternal tontivl as the trustees delei"stlllle is netessary to eEiable the pirpai'alion of ftnancial stat¢ihci)ts that air fire from iTralei'ial rnisstatcmEllt. wlittlier due ttr fi'aud or ctto¥. In preparing tht fii)anci81 ststemeat4 th¢t￿st¢t$ ai"e responsible foi'assessittgthe ¢haritable coinp&iy's abilily lo Continue as a going coneern, disclosing, as appliGabl¢, IRatters Irlated to going cono¢rn and iising tli¢ going con¢¢m basis of accouiititlg unl¢ss the trustees either iajtend to Iiqliidate the charitable Lon]pany or to cease operations. or have no T&ali5ti¢ alteTnative but to do so. Audttoi s respoijsibilitie5 for the audit of tlie firt#iJtial stxttintiits OLirnhjecttvc8 arc to obtain i'easonablc assurance about whether the finan¢ial statements as a whole al'e free fiDin material misstatemetit. wlieihev due to fraud oi. en￿L., and to issue ali auditoi s ieport that incliides our opinion. Reasonable assiirance És a high level of assui?n¢e, but is llot a g￿aral]tee tliat all audit conducted in accordance with ISA5 {UIC) wÈll always detect a inaterial nTrisslalem¢ot when it exists. Miss(aÈeineiJts can arise froin fraud or en￿r and are eojisidered material if, iiidividually or in t]ie aggregate. Ihey could re8sonably be expected lo infliience the economic dec*sions of users t&k¢n on the basis of tljese fsiiancial staterncnts. trregularities, including fraud, are instances of noii-coinpliance with laws atkd IrgulatiotEs. We design procedures itt liiit with our responsibilities, outlined above, to detect Jnaterial misstatements in respect of irregularities. includiiig fi'aud. The extent to wliich OLir procediir&s are capable of detecting iiyegiilai'ities, incliiding fr&ud is dctailed below.. Based on oiir understanding of the charltable company alld the environment in which it opeyates, we identified that Ihc pi'inGipal ii5k8 of non-¢omplian¢¢ with laws and i'egulations itlated to thc CoInpanics Act 2006 and Cliarities Act 2011. and we consid¢red the extent ID whicli non-coinpliance might have a inaterial effect on (he fuiancial slatemejits. We also considei'ed those laws aiid regulations that h&v¢ a direct impact on tlie preparation of the financial staternents such a8 payTvII tax and sales tax. We evaluated i)ian&geiiieiit's incentives and oppoituiiities foi. fiYiidLilent tiianipu12tion of tl)e financial 5tateiiien15 (incliEding thr risk of ovei'rid¢ of ¢onlrolsl. and deteiniillcd tliat the PTincipal risks were relaled to posting iiiappi'opiiate journal enti'ies to revellile &nd management bias in accounting esti2llates. Audit procediires performed by the ellgagetnent team inclLJded.. Inspecting COTre5polldence with reglllators at]d tax authorities- Dis¢us$ions with illai￿gel￿¢llt inGluding roiisid¢i?tiDI) of known or susperted instan¢¢s of non-¢onipliJn¢¢ with laws and ¥egtslation and fraud., Evaluatin8 Iiiaiiagemeiit's controls designed to pvevthl a￿d detect irJEgularities,' Review of minutes of meetings Identifying and testing journals, in paiticulRr journal entries posted as parl of th6 year aid p¥ocess' Challenging assumptions and judgeinents made by man¥tgenient in th¢ii' ¢riti¢al a¢¢outtting estimates 17 Registerrxl coinpany nUmL￿r.. 02645706

I'li¢ ]JrltFslI SD¢lety tor HI￿17￿t010gY (Limited by E￿Atro0￿cl IndtDQiJJoJii auditor'5 IEPOI't Year endeil 30 Scpttmbcy 2023 Because of the inherent limitations of all audit. there is a risk that we will nol det¢¢t all irtcgulaiitlC5, incliiding tl)ose leadiiig to a niatci'ial inisstatement in th¢ finaiicial staltmeiils or noN-coinplia#ee with iegulation. This risk increases the IIIOTe Iliat coinpliance with a law or regiilation is reinoved froni the ¢vents and tTansactioJis reflected iti the fitiancial statemeiits, as we will be less likely lo be£ome aware of instances of noii-cotnpliance. Th¢ i'tsk is also greater regai.ding iITe¥ularities occurribg due lo fixud rathei. tlian errol., as fi?ud involves intentioiial concealmertt, forgery> collusion. omission or I￿l5￿presentatiOn. A further d¢scriptioll of OUT JrsponsÈbilities for the audit of the financial slalements is lotated on the Financial lieporting Couttcil's website at.. www.fr .uklaudilotsres onsibililies. This descE'lPtiott foTlliS part of oui. 2uditoi s report. Use of out. a'epoi't This report is Inad¢ solely to the cliaritabl¢ Goinp&tsy's m¢illb¢rs. as R lJ]dy, in accojxlance with Cliapter 3 of Pait 16 of the Companies A¢t 2006. Our audÈt work has been undertakcn so that we might state to th¢ ¢h&L'ltabl¢ company's Ineillbers those matter5 we al'e required to state to them iii an Audilor's i'eport and for no other PLlfP05e. To the fullest extettt permitted by law, wedo not 8c£eptorassume i'esponsibility to anyoneother thaTr thc cliai'itable colnpany and Ilje charilable cornpaijy's inembers, as a body, for our *udit work, for this report, OT fo¥ the opit]ions we have forilled, I'homas WÉlson (Senioi. Statuloiy Audiloi.) Foi. &tid on behalf of l-laysmacintyip LLP, Statutory Auditoi. Idat¢l 01105124 10 Queen Street Place London EC4R IAG Registered company iiumber.. 02645706

Tlie British Soticty for Ha¢matoloEy ILimile(I by guar￿￿te¢l Const>lidAted $LtcmcJit of fillAJicial qetivities YeAr 30 September 2023 Gciieral riunds Designate(I Fullds Total 2023 Total 2022 Notes n¥coME FROM: DotHiorn% Charitable actiwties.. 705 243,874 1,093.573 35 1,363,672 139.082 243.874 1,093,573 35 1,363,672 139,082 233.868 1,144,431 307 1,175.034 52,465 Pi'ofil Shal'e ofJotsrnals Incoijigfroin ihe COnf¢F'ery￿s In￿stn1£n1 income Totsl iiico]llE 2.840,236 2.840 236 2,606,810 EXPENDrruRE ON.. Raising funds Invgsliiienl MiFJTageBiei¥ife8J' 36,018 36,618 35,855 Ch￿'itable acttTrities'. RESe￿i.ch Ed£tcÉ>llcI￿ ttipdaiiJai'eKets COJI of Coiifeiejices 618 227,139 1,233,664 929,373 62,917 145,866 290,056 1,379.530 929 J73 297.020 1,134.075 1.014,224 TotAI exyenditui'e 2,426.794 208,783 2,635.577 2,481 174 Net income E¢fore investtnentgains 2nd tsansf¢rs 413,442 1208.7831 204,65() 125,636 Net Ilossesll gain5 on ITiirslmeitt5 N¢t inwTD¢ and n¢t m0￿ment fi]tKJs 207,813 621,255 207.8 13 412,472 758,551 1632,9151 {208,783) Trangfrr belweert f￿d$ 1446,440) 446,440 Fulld Ixlances Wf 10,591,437 149,885 10.741,322 11,374.237 Ind balanctt clf 10 766252 387 542 11 153 794 10741322 All recognised gains And losses al'e reflected throiigEk the Statement of Financial Activities. All activities rel]¢cted above are continuing adiviti¢s. The accotnpanying notes on pages 23 10 40 form payl of th¢ a¢counts. 19 RegisiBred ¢onipany iiumber 02645706

The Bi'ilisl SD¢ieiy foi. Hacmxtolo¥y (Liinrled by guAranteel Consolid¥te<l Balante Sliet At 30 Septeml)ei' 2023 CoMpA￿Y NumbEI': 02645706 21123 2022 Note FIXF.D ASSEI Taj￿Ible ￿$¢￿ TttwslineDLg 405.941 8,118,722 421.263 7.848.147 8,524,663 8.269,41 uRRE￿pAsSEl]s Debtors C3gh a itth￿d 4&8,473 2,688,534 3,157,007 617,1164 2,324 781 2,942.245 CRf4DIII)RS.. fdling the 1527,8761 1470.3331 NET CURREI NT Assrrs 2.629,131 2,471,912 TOTALASSlIlS LFSS CtWiENTLL4BiUTIES 10,741.322 N£IT ASSETS 10741322 UlYRESTRIC￿,D fiUNDS: Geneial fEuiILs Designated fu 10,7(NS,252 387 542 10,591,437 149 885 10741322 The fInaiicial statements weye approved and authorÈscd foi. issue by the board of'fru5tees on . and wyre signed Dtt ils byhaifby . -..Af.IL-1021p,. r Josh Wright Trustee J'resident hei'oft 5ul.er Stee The accompanying notes on pages 23 to 40 form part of the accounts. 20 Ae8iStered coiknpany niilliber,. 02645706

'rhc Bi'Ltiyh Society fthr IIAeMfitology (Limited by gTiaranteel ClIRI'itRblc CDmpiiy BAlN¢e Sh¢¢l At 3D Sept¢nibÈr 2023 Comp2uy Nuiiiboi. 01645706 2023 2022 Note FL¥ED ASSft3 Tiingiblc 8sset5 IJ)￿S1n1ertts 14 15 405,941 8.118,724 421,263 7,8&18,149 8,524,665 8,269,412 CURREwfASSLIlS Dcbtois Cash at bank dnd iii hand 16 432,060 2.055,156 2,487,216 425,959 2,197.33() 2,623,295 CRF.DITORS.. th9￿1$ E￿ling (kne itlun on¢ year 17 1443,7461 463,924 NKTCURRENT ASSE75 2 043,470 2 159371 TOTAL AS8EI5 LESS CURRENfLW3ILETtES 10,568,135 10.428.783 NET A&8ETS 10 568 135 10428783 UNRKSTRicfEI D FUNDS.. General fund DeSi￿ated ful￿$ 18 18 10.180.593 387.542 10 568 135 10278,898 149,X85 10428783 The financial stateinents were &ppi'oved and authoi'ised for issue by t￿e board of Trustees ts2) aiid were sigtt¢d 011 its behalf by Di. J05h Wi'iglit Ti'u5tee And Pi'esident 'oft urer tce find- re Thc arcompatiying iiotes forni part Df the a¢counts. As perniitted by Section 408 of the Comp&nies Act 2006. no separate Statement of Finallcial ABtivi1165 OL. Income and Expendituir account has been present¢d for the charity alone. Income of the parent chaTity alon¢ amouftt¢d to £1,642,824 (2022: £1,794.2361. Net income of the c[￿rItY aftcr realisedluiirealised gains on investment5 amounted ¢0 £139 J52 (2022.. {n¢t cxpenditure) £347.2061. Registered compaiiy ttumber.. 02645706

The British Socioly fDI' HRemAtolDgy ILimii¢d by guRI'allte¢l Coiisolidte(I CA51J Slal¢mert Yo$r ¢n(leil 3fj Scplembei- 2023 2023 2022 Nel c&8h byllused in) OPBralingaBriviti¢s 292,283 1167,4291 DiNideikls and inteiul PLYeh&4e of iniE3lI￿enl5 139,082 52,4&5 12,378,650) ITtKrea%c) in investnient cts&h Paytnenls LoAcquirc Isx¢d1￿5els Netca5&iw￿vthd byiiiK$lin8￿&IlrytieS 36J.753 {142.4701 24.781 2467251 C8sts CAshequiYal¢nts Ht tli¢ eiidofllie i'tpoi'llllg pei'l• 2 688 534 2.324 781 NOILblUTHKSIATLTrL IEwror CASII FLOIVS Noi IiioNEment in ftuids.. Nei8oinon iiiitstillcrts Depreci￿101 DtertÈseJlinere&%el Indeblois ittreaseldEcrea5¢ In¢reditots DiMde]￿s, li¢rests￿drÈrnts from i1￿11￿¢￿15 412.472 20,172 148.991 57.542 20,147 152.4651 Not cash pl.￿vi￿E￿ byllu¥cdiJil h¢livitir$ 292383 167429 IIIIAiilysls ofcashandcpsh equiv91oJils 34 2 324.781 The accompanying notes form an integral part of tlies¢ a¢rounts. Tbere were no dcbt an'ang¢mentS el)tei'ed during the year. 22 Registered cornpany niimber.. 02645706

Tbe Britisli Soeicly fTri' 14aetuAtDlo¥y ILiJb)ittd by EuHrallleLI YeAr eiLd¢J 30 Septetnlier2023 COMPANY sfATUS The cotnpaiiy is IiEnited by guarnntee, not liavijig & share capital. The meinbers undertake to contribute to the assets of the Company in the event of tt being wound up, either whilst Inembers or witknin one ye&r of the meiiib¢rship ceasing. Tht JllaxiTniEm ¢oiitribution required fiDFtt each membei" is £1. There were 2,955 active 6rnber5 at 30 S¢ptembei' 2023 {2022.. 2,947). ACCOUNTING POLICIES Statement of compliamee Tlit financial statcments have been prepai'ed in accordance with A¢¢oiinting and RepOrti￿g by Charities.. Statement of Recoillmended Practice appli¢able to charities piEpariJig their accounts in accordance witli the Financial Repoiliiig Standaixl appliGable in the UK aiid R¢pubSic of Ti'eland IFRS 102)- (Cliatities SORP 2015 (Se¢otid EditÉoii, efftctivc l January 2019), the Fillancial Reporting Slandaixl applicable in tlie UK and Republi¢ of Ti'elartd IFRS 1021 and the Coihpaniex Act 2006. Assets and12&biliti¢s aiE tnitially rccognised at historical cost or transaction value unless otherwise stated in thc relevant aGcDUllting pDli¢y Iiot¢s. General infoi'mfitio Thc Charity is a company limited by ¥uaTarttee, £ncoJporat¢d iii Englttnd and Wales (company llunibeT.' 026457061 and a charily irgistered in England and Wales (chai'ity t]utnbei': 1005735). TIIE Cliarity's i'egistci'ed offjce address Ès 100 White Lion Street, London Nl 9PF. Tlie British Society fo¥ H&eJnatology meets the defjnition of a publi¢ benefit etTrtity under FRS 102. Coaisolidatlon The accounts consolidate the fii)anGial statements of The British SocÈ¢ty forHaernatulogy dnd its wholly-own subsidEary, BSH Bnt¢rprises Ltd, on a linc-by-line bilSIS. Trdiisactions aiid balatLce5 between the charity and its subsidiary hav¥ eliminated the consolidat¢d tIManci&l statements. As pemiitted hy 8ection 408 of the Coiiipanics Act 2006, llo separate Statcmentof I'in&nGÉal AGtiviti¢s or Income atkd Expenditure a¢coiini has beeti presented foi. the charity alone. In¢otn¢ of the p&iEiit charity alone ainoynled to £1,642,824 (2022.. £1,794,236). Net kncome of the chaiily after IEalisedlunr¢a]ised gains on investiE]ents amountEd to £139J52 {2022= (1)et ¢xpeTrditure) £347,206). Going eoncer The Ti'ustecs have reviewed th¢ Reseives Policy and the forecasts foT th¢ next two yeai's and conssder that ¢hev¢ are no matei'ial uncertainties about Tlie British Society for Haciiiatology's ability to contÉtJue iii ex%stence aild Lt has adequate resourccs for tlic neai. fiituie. CiinEttt levels of illvestTllents and cash funds aye in excess of the Reserves Policy and the Cliarity has the ability to GUrt8iI expenditure to a niinimal level of overheads. Evel'y quartei. the FIiRC reviews mallagcmetit a¢couD15, budgtls, and 24 month &95h projections. The budgets prepared for the coming fillancigl yeitll. Wtll Carefully cotLsidei' the control ot'outgoing expcllditllre to be in lin with the CiinBiIt income stlEams, any effect on levels of income diie to the pandemic, and any hnciEases in incorne resulting fiDni the pix>jects to diversify and in¢r¢ase incoime. 23 Registered coinpany number.. 02645706

The Bi'iliib SD¢iety f•i' HaEftiatol&gy ILimit¢d by giiRiTrDtce Ytai. en(led 30 Sepl¢mb¢i' 2D23 ACCOUNTING POLICIBS (contiijued) Ci'itical HCCOUllting judgements And eSttm1)t￿ #nd key sollrcos of Èstimation uneertgin¢y In the applicattoii of these accountlllg policies, the Tvustee5 are required lo make judgenienls, estitnates and assuillptions abolit the ¢aTiying valRJe of a55els and liabilities that ai'e not readily aPPa￿￿t fiN)tn other soiiires. Estiitiates aiid judgemejits are cot)tiiJually evaluated and ￿'e based on hi5tai.ical cxperEellce and other factors, inGludiiig expectations of futyre ev¢nts that are believed lo be reasonablr undei. the ¢iirymstaiices. Altliou£h these estiniates al'e based 011 tiianagetneiit'5 best knowledge of thc &mouDt, events or actions. actual results may littl1￿atelY differ from those ¢stimate5. Revisions to accouRting esliinates are Ircogni5cd in the period in which the estimate is r¢vis¢d if the i'evssioi) affects only that period oj. in tlie pei'iod of the revision and fvture pei'iods if the revision affttyts ¢urrent and fvture period8. Th¢ TiiJ5tces consider tlie following it&ns to bc ai'eas sUbJ￿t to estimation a￿d judgement.. Depreciation.. Tlie useful econojnic IEves of tangible fixed assets aTe based ott tnatiagement's judcFeiiieiit #nd expei'iellce. When management identifics that actual ustful ECOROrniC lives diffei. niatei'ially r￿n7 the eglimates used to calculate d¢pr¢ciatioJi, that charge is adjusted retrospectively. Although tangible fixed assets ar¢ sigiiifiLdnt, vai'iances betweea actual aiid estimated iIseful ecot)omic lives will not have a material iInpaGt on the operating i'esults. Hisloiically, ijo changes have been TequiJEd. Iii the view of tlie TtU5tees, no assu1￿ptiOlls concerning tlie £IT￿re oi. estimation untertainty affecting assets OY lizbilities at the balance sheEt date likely to result in a mateiial adjustment to th6ir carrying amouijts in Ilie next finatJ¢ial year, Thc following accoiiiitinx paliLies have been applicd consistently in dcaling with items which aiE constdetEd aterial in relation to the financial statcm6Dts. Income All incom¢ is recognÉsed when the criterEa of etttiilemeiit. measurement and probabilily of Jrceipt have been satisfjed. Membership subscription income is accounted for on an ac¢rual basis and repi¢sents only that part of the subscription which vel?¢es to the finat)GÈal ytai. in which it is paid. The balance is included sJ] deferred in¢ome itE creditors oji tlie b8lan¢e sheet and releascd in thc pcriod In wliich it relates. Dividend Tncome is accounted fo¥ in the slatem¢nt of financial aclivities in the perÈod in wlii¢h th¢ cliarity is ¢ntilled to receipt. The profjt Share JEceivable from John Wil¢y & Solls Ltd in ￿Spect of BJHaem and eJHoéi* is recognised on a receivable basis. Turnovei. in BSH Ellteiprises Limited represethts the ainouijts (excluding value added tax) d¢i'ived froni the pIDvision of the aniiual conference for'fi)e BTiti511 Society foi. Haeinatology. T￿rnOVel. is actyounted for tkn an accrual basis with incon}¢ recognised ui tlie profit afjd loss accoLint for the confe￿￿¢¢ ¢o¥tLpl¢ted iii the current accountitig period. Deptslits re￿ived in respect of the conference in the next accountEng peTiod are held in defrrred iijcome in creditoiB in the balaiice sheet al tli¢ year end. 24 Il¢giskTcd cuIiipany number.. 02645706

Tbe Brit1511 SDciety for HA¢ni$toloEY ILimited by EU#J'iinl¢el Y£%r cnded 30 SEpteillb¢i' 2023 ACCOUNTING POLICIES Icontinucd) Fxpertditui'e Liabilitits ar¢ I'e¢ognised as resources expended as soon as thejr is a legal oi. coiistructive (Ibligation committing the charity lo the expendituj'e. Expenditure is acroiinted for on an accriials b&sis and has beEn classifled under lieadings that aggrcgate all Cost related to th¢ eat¢goiy. Where costs cannot be diirctly atti'ibuted to particular headings, th£y hav¢ been allocated to &ctivitlC8 on a basis consistent witli the use of i'esources. ExpenditUiE Is cla&sÉfied under the following activity headiiigs.. Costs of raising funds coTnpi'15e the cogts of investti?ent managenient and other support costs (hat do Trot i'elate directly to £ep8rate cliai'itable actÈviti¢s. Expertditulr on chw'itable activilies inGludE5 tli¢ Gostg of PiDjects on liealth and edu¢Ation alld their assaciated costs undeitaken to ￿l*her Ilie purposes of the ¢hars1y. Siipport costs liave beeli allocated to diT¢¢t activities based on the total diirGt Costs of eadi funclion. Irrecoverable VAT 15 Gh&i'ged 85 a cost againstthe activity fov which the expejiditiire was iiicvnrd. Gr8nl ￿}yArdS BSH invites applications foi. fvnding of research start-up gi?nts for young inv¢stigat013 in haejnatology. BSH also aW￿T￿ts sludttnt scholafships and 5ebolasEhips lo assist haeinatology prof&s5ifJnal8 to visit ovcrseas iL)Stitutions for the purp)se of Itailling new rasearch oi. clinical techtiiques. lil addition. BSFI awai'ds ti'avel scholaTships to rnahle haematology Thursc5, physi¢i8rt associaÉeg, stude2its, dootots or sciEntists li) training to ottend ovei'seas meetings. AppliGations are made lo the KeseaTeh and Grants Committee, which is assisted by independent expert reviewers for th¢ highEI'_Vdlue rescarcli gl'ants. Th¢ Boayd of Trustees approve5 annual grant budgets and Yeviews expenditure rcgulai'ly. Tli¢ liability foi. die grant is rewgnised at the point the relevant comi#ittees authoi'ise tlie award of the grant. OpeY&ting leases Rtntals payable iiiider operating leases ale ctLai'ged to the 5tatcm¢nt of financial ac¢Èvitie5 over the temis of the lease. Shoi't-tei'm b¢ntfxt$ Shoit l¢rni bentfit5, in¢luding holiday pay, are re¢oBnÉsed as an expel￿¢ sn the period in which the seivice is Yeceived. Pens5ons The Charity conti'ibytes to the NLST defined cotttribytioii scliejne, coiitributions arE made in 8c¢ordaDce with the n]les of the plan and aye chai.ged to expenditiiir wli¢n they air payable. mployee teiThinlltÉon bpnefits Terminatson benefits are accoutkted for on all accrual basi5 and in liiie with FRS 102. Fixed asset investments Quoted investments are slated at mai'kct value at the balance sheet date. ThE siivesl¥nent in the subsidiary company 15 in¢liided in the accounts at C05t. FixEd as5e(s Aiid depteeiation Items are capitalised if cost is greater than £1,000, otherwise they al'e wi'itteii off directly ta the Statement of FinaE]cial Activities. 25 R¢gi5tered compkw Rumber.. 02645706

Tlic Bi'itisb Society foi. Hll¢matolog3' ILimile(I by gilal￿nt0el YeAr ¢ndtd 30 Seplemb¢r 2D23 ACCOUNTING POLICIES {¢oiJtinuedl Depreciation oil these assets is provided to write off the Bost of tangible fixed assets by equal *nstaltnents over th¢ii' estimatcd u5¢ful ecoiioniic lives as £olltsws.' Lo￿g leasehold property Office eqiiiptnent over 50 yedrs 20% pei. aiinuih TAxAtion The Society was registered ￿ & cliarity iji November 1991. Under s505 ICTA 1988 the charity is not subject to taKiltion on ils charitable activities. Tlje profjts of the rton-¢liai'Ltable subsidiary al'e gift aided to the PBlfllt compAny at the Directors, discretion. Any sui'plus remaining É5 subject to & laxatioji charge. The ¢harge foi'taxation is based on the IfSLilt for the year. Fund aecouDtin The Society has tbe following typ¢s of fvnds for wliich it is iEsponstble and which requir¢ separatc disGlosures. Cenei'AI fufftjds Getterdl funds &lE Ullresti'icted funds, aiid these aiE ¢xp¢ndable at the dis¢retioii of the Tjustees itj ￿rthera￿ct of tht objectives of tbe eotnpany. ltt &ddEtion to expelldituiE on the principal objectives of the ¢oinpaiiy. such fiiijds may be held in ord¢¥ to f111an¢¢ Gapital iiivesthiienl alld woi'king ¢apital. DeslgnAted funds Designat¢d funds comprise iinrestricted funds that have bren set aside by the Tiuslees foi. parttculay pliiposes. Restritted funds Restricted funds arE funds subjected to specÈf(c instructions by tlie doiioi., but still within the objects of the cliarity. The So¢i¢ty ￿rrentlY has no Restricted Fiinds. Ti'xnsfet's betiveen i'¢scrYc5 I'ransfers betweeii general and designated fuiids a¥e made #t the Trustres. discvets011 to set aside fynds a5 reqiiired. Fin4nciRI Instruments The charity only liolds finan¢iol asselg and fIi)ancial liabilities of a kind that qualify as basic fiiiaiicial insts'uEnenls. Basic financial insti'uni¢nt5 include trade debiors, accrued in¢0￿C, other dcbtors and loan amoiijits due from subsidiary undeJt&kings. Basic fit]alleial liabilities in¢lude ti?d6 creditors, accruals. and otliei. creditors. Basic financial instiwmettt5 are initially rccogiiiscd at tranxactioft value and B￿b$eqUentIY meaSU￿d at their settlement valu¢. Debtoi's Trade and other debttii's ai'¢ I.ecogn￿sed at the settlement due after any trade discount offi￿d. Prep&yments are valued at the amoiiot prepaid net of any trade discounts du¢. Ci'editors xnd provisiolls Ci'editors provisions are Ir¢ogiii%ed wh¢re tIEe charity h8s a piysent obligation Yesuliing from a past event that will probably result in the Iransfei" funds to a tliird paity and th¢ atlloullt dlle to settle the obligation can be mea5urcd or estimated reliably. Cr¢ditoJ's and provisions are normally recogllis¢d at their 5ettlernent amount aftei. &llowing for any trade discounts due. 26 Regist¢ird company nuniber.. 02645706

Tlie Bi'itisli SDciety for HaemRtoloKy (Limited b). gu*i'Alltte} Yertr eiiileil 30 SeptenJb¢r2023 DONATIONS 2023 2022 Gellct'al fuTrd5 Doilations 705 TotAI donAtions 705 OTHLIRINCOME 2023 2022 Geijeval fllnd$ Siiiidiy income 35 307 35 307 INVESTMENT INCOME 2023 2022 Genej'al funds Dividelld and returns fi'om invc5tmettts OtheT iJJleTesl ￿￿1Vable 78,791 60,291 47,388 5.077 139,082 52,465 27 R¢gTstered Co￿p￿TrY Du￿ber 02645706

I'ht B Yitish Soeitty foi. HRemlltDIoEY ILimiiL,d by gu#rAnteel Year tndcd 30 SEPtonJbei' 2023 RLSEARCII 2023 2022 Res¢w¢l% is a¢1￿c￿￿thrOl￿ the ￿)￿llellI tsf Ibt follo1￿ng gr￿1$.. Eatly Stage Researcb 51arl lip ST￿1[2022.. gtallt iepEidl BSII-ASèI Abs1[￿1 AChiC￿men1 Aiwds T1&￿1 Scholar.4hik Slurkiilelecli￿S BSHASM Scholsrships.. iii¢ludiiE forstithnts Seithilific MeElln8 511pwrl Vi511ingFellow Glts￿ Hae￿91010gYB14ThL% & SIG Ifwrti Desi￿1¢0 fiiiittsl CohDrt slildy8r￿iI IfTOJll Desigpaled FIiDthI O BrgJMS",2022 1 grant 2 ￿￿1￿$",2022 0 8rthS 6 g[￿$. 2022 0 graMIs 23 ￿tsnts. 2022 15 grants 39 ￿￿1$. 2022 19 Bt8iIIs I grwii.. 2022 4 gnnis l Etanl., 2022 0 g￿lIS 4 gra￿ls.,2022 2 grwits O grwi15' 2022 18rant 16.3741 8.706 5,630 20,897 1,969 4,157 6,378 3,040 1,000 15.000 40,519 14.263 49,812 01.995 79,619 Supwrl c051515¢e not¢ 81 Blood CwJceT UK Ifiom De%]g￿e& Fill￿) 165.663 22J98 19.799 97,602 290 056 297 020 Atotsl of 7612022.. 421 ￿8￿lS wt aiM]rthd in the yeBr. Jncluthdinih¢ the fDIIo1mI￿gr£01S paidro i￿lI111110￿. All srary15 aiiFr(kd d￿e¢llY lo indiiiduais. 2023.. Uiiiwysity of Oxford£l,UDO 2022.. ulu￿[SI1Y￿[ O.¥ford £49,812.. unI￿lSilY of C￿nbridg¢ £4.628 Aft￿ the CovidpAndeiJic the BSH of the Coiidva¢¢ln￿IQTh F*inthTrgCo1lalx)rati￿ ledby Bloodcancer UK. Thr projwl Garlics Dui rcsrarcli iiilo ¢iTic￿y0f coiod vacci￿ for people Mqtli blood c3ncer. Atoid Df£150,000 dBsiBnatcd foi thc DSII lo ass151 ￿ this collthial1￿ ￿ld fula] paynenl of £22.398 h¥s ￿en p8idthis year to Blood c&￿er UK12022.. £97,602). 28 Registered compgny iiuinb¢i': 02645706

Tlit Ilrilisli 8&ciety for HReinAtolDgy (Liniitcd Ii). guai'asit¢EI Nvtes to tht fioinciAI 5t2tenieiits {coJiliiiiied) Y¢Hr ende<l 30 Sopt¢mbei' 2023 EDUCA170N AiYD AWARENESS 2023 2022 Guidelilles Costs.. comi￿lttee genergl expenses Hacmatolo&vltlironibosis tzsk LileratuiE searches & Medscal w'iting Retired CO￿￿[t￿lS & traiii¢es Digit￿ M¢diit costs EducatioJb&l comrniitee L¢￿'nIng hqry¢t￿nt Syst¢Tll Costs Workforce Support coll51i1iancy Paedialric SIG t￿ntS Obsieiiic SIG ¢Ktnls Lgb SIG e￿n[S Lymphoma SIG t￿ntS Egrlycareers Porutn SIG Pro￿arnMe Committee expetses Educal(onal Sernices & Joui'rwls AnDual Science Meeting Costs Priz¢5 & FXc¢l1e￿e Amwrds Website C051s EdKalional ENrn¢5 CD5tslllncome} contr1￿110n to external cTrEnls Wilkinson Lecture cost {from D￿ls￿￿ted Futtd81 Worlrforce S￿r￿Y& Campaigning(D¢si￿￿t¢d Fund tliis yearl 2020 Anniwrswy Comnjemoi'alion Cosls Ifiom Dcsi•cd fu]05) 50 125 15,721 400 9.098 340 3,790 28,131 2,700 16.695 6.443 2.149 9.000 25,144 4,601 3.264 12801 280 255 2,000 127 108,555 1,731 3,750 116.026 9,942 8,000 144 145,722 144,918 375 3.250 237,552 ,203 6,500 120 16,369 471.183 462,863 SuppDrtcost5 {see nott 81 916,667 662,892 1,379530 1 134,075 29 R¢gist¢r£d compRny numk¥'. 02645706

The Bi'itisli Society for IJA¢nJ&tolog}' ILimitc(E by E￿al.￿nte￿I NDte5 lo the finaiieial sllllomcnts (COJllllTlied) YeAr endtd 30 S¢plembEr 2023 IXPENDII'liliE Dli'ect tosts CrAnts poyAble Support costs TotAI 2023 Cost of raisingfunds JNIiEsliiJeFtliiiana¥eiJienifees 14,530 22,088 36,618 Charitable aetiiuti¢s Resedi'ch Ediiculioii rtiidL7TVai'ÉNeXS Cosl ofcoiifep'eitces 22.398 462.863 929,373 101,995 165,663 916,667 290,056 .379.530 929,373 1.429 1(A 101995 1 104418 2 615 J77 IxpfrNDITtJRE PRIOR IKIR Divtct costs Grrtnls pa3uble Support C05t8 TotAI 2022 Cost of 18ising ft InveslnTentr i1￿11￿gejI1e￿1fe￿S 19,882 15,973 35,855 Clizritabl¢ actiiilies Retreaiyli 97.602 471.183 ,014,224 79.619 19,799 662,892 297,020 1,134,075 1,014,224 CoslofConfei'eiiceJ 1602 891 798.664 2481 174 Th¢ of allocationof siipwrt costs is IKLqedon Énallocationof estitDated staff tinK. Support COBts- othEr 21J23 2022 SaS¥trits &olher staff Gosts Premises costs O￿lte ￿ld cornpu¢in8 Professio#£l fees qarktting I, 796,830 76.853 78,865 30,063 18.647 12,529 .013,787 592,132 59.202 60,760 46,888 ,358 761,941 Support tost$- govci'nanct Audst ¢05ts tzgdl Costs Trusrees, & Co￿ri￿￿¢ ill¢¢tings 13.600 15.127 61.904 90,631 12,255 3,504 36.724 1.104,418 798,665 30 Registered company number., 02645706

Tbt B Yitish Soeiely foi. Haemfitolo￿ ILilliited by guarantvcl Notes to th¢ fiJiaTr¢iil slhteinents {coiilèJJiied) I'eai. ¢rtd¢il 30 S¢ptQDiber 2I23 INVE￿MENT AND OPERATIONS IN TRADING SUBSIDIARY The wholly owned tradittg SLibsidiary, BSH E,nterpriscs Limited (02677826}, which i5 sncorptsrated in the United Kingdorn and ITgistered in England aTrd Wales. pays ils pl￿rit by Kift aÈd al the discretion of th¢ Dii'¢Gtoi's. BSH Elltcrpri5es L]m￿ted operates the Annual Scicntiflc Meeting {ASM) and all coinmeirial tradsiig opeTatIOTIS. The chai'ity owns Ihc cntire issued shaJE capital of 2 OJ￿iE)￿Y 5hairs of £1 each. A summary of tlje ti'ading r¢5uIts 15 shown below.. 2023 2022 Tuynovei. Cost of sales Gross Ilossllpi'ofit Administratiw exFnses Operating (loss)IprofJt Fiiiance Costs Interest i'¢ceiwble Profstl(loss} on ordinary activities before taxation T&Kation Gift Aid paid 1.363.672 913,786 449,886 19.985 429,901 (1242) 138 428,797 1,175,034 1,004,857 170,177 13,872 156,305 (1,136) 155,175 (155,677) (440,884) 273,120 285 709 The &8sets and liabilities of the subsidsary werc.. curre￿ assets due within one yew. Debtors due after more than one ye￿. Creditors.. aniouiit5 falling due within one yeai. 669,791 308.183 16,407 12,049 312 541 84,130 585,661 Sl)are capital and resernts 585,661 312,541 31 Registered cotnp8ny nuniber.. 02645706

Ihe Bi'itish Society foi. Ilktrnxlology ILiiJiÈlod by 8uRJanleel Nole5 (ho fi￿￿￿¢*Al statements (conltJiiiÉél) YeAI' eb(led 30 StpteiJJber2023 10. NET INCOME 2023 2022 Nct ancome is slated after charging.. AllditoiE reinLinei'ation'. Audit of the5c fii)ancial statenjeiits (excluding VAD Audit the siibsidiajy financial statements (excluding VATI Other seivices Dtpreciation 11,100 6,230 2,500 20,172 9,680 5.350 2,100 20,147 Ai. REI MUNERATION OF TRUSTEES The Trustees l'ece￿Ved no reinun¢iBtion dui'ing the year, oi. tlie previoiis period. 10 Trusttts Èr¢cived rclinbui'sement of expenses in the yearof£4.87712022.. 9 Ti'ustees. £2,257) Tlieseexpenses related to travel attd siibsistence nece8sarily incuyird in th¢ peTforniance of tlieii. duties. No amounts wej'e paid directly to thErd parties. 12. STAFF NUMBERS APID cosrs The avetyge number of persons, eiyjployed by tlie BMUP dijring the year {excluding Tr￿St¢£5 and DiJ'ectot%) was 14 (2022.. 11 l. The averdge nttinbei. ofpei'sons ittcluding temporary st&ff was 16. 1.hc gLDUP aggregale payroll tosls of these persons were as follows.. 2023 2022 Wages and salaÈry¢s Sobial 5ecui.ity costs Employers pension lemporary staff 557.676 54.882 39.740 77,023 405.179 40,085 33,345 93,232 729,321 571,841 TheTe was l employee whose emoluments for the year were betwe¢n £60,000- £70,000 {2022: 1). The key Inan2g¢ment personnel of the groiip incliides the Trust¢B5 and DiiEcÉors of tlie Senior Maiiagement Team. No Irustees were iEMunEI'ated dui'ing the year (2022.. nil). Total rcmuneration to the key maiiagemeLt personnel was £73,85312022.' 74.1441. 13. TAXATION Tl)e company. wlii¢h is a registered charity, is not li&ble to taxation on thenet income from its charitsble activities. 32 R¢gislcr¢d compatry number 02645706

T]Je Bi'iti4h Society foi. Haenilltolo￿ (Limited by giiai'liateel Note5 to the fiuanciHI $tat¥m¢nl$ (¢oniliitiedJ Yeai. ejjded 30 S¢ptembei' 2023 14. TANGJBLE VIXED ASSEIS Property & tmprovements Offiee Equiilment Totsl 2023 Gi'oup and Chpi'itable CoD]pany Cost At l October 2022 Additions Disposals At 30 September 2023 604.759 49.640 4,850 654,399 4,850 604 759 54,490 659,249 Depi'e¢iHtivii At l October 2022 Charge for the year D¢pr¢ciation on disposa15 At 30 SepteEnbcr 2023 192,133 13,840 41.003 6.332 233,136 20,172 205.973 47.335 253.308 Net Book Value At 30 Septenikr 2023 398,786 7,155 405.941 At 30 September 2022 412,626 8,637 421.263 33 Regist¢r¢d ¢oiJipat)y numb¢¥'. 02645706

Tlie Britisli SDeitty for H￿e￿at￿log}. ILiiiiiled by EuArAntcel Notes to tlio finaiicial 51&ttrhents (conliryiied) Yc4r ¢nd¢d JO Septembei. 2023 15. FIXED ASSET llYVESTMElYtS 2023 2022 Croup Investments at l October 2022 AdditiOll8 Di5POsals Realised gait*llossesl Um'ealised gains Total Investhients (excluding ¢ash) Cash held in investment portfolio at 30 Septeniber 2023 URlÉst¢d investments At l October 2022 Additioiis at 30 September 2023 7.696.016 1,929,731 (1,732.8 121 8,547,106 2,378,650 (2,471,189) (209,9171 (548.634) 7,696,016 152.030 7.848,046 191,700 8.100,748 17,873 8,118,621 ioi ioi TotAI Investtllents gt the end of tht y¢ai' 8,118,722 7.848.147 Historical wsts of listed inv¢stm¢iits arc £2,700.523 (2022.. £3,418,883) CharitAble company Listed Investments At l Octobcr 2022 AdditiotTrs Disposals KealÉsed gainsJ(loss¢s) Unrealised gain5 Total Invcstnicnls {excludillg taEh) Casli held in In￿'St￿¥￿t P()TtfulTV At 30 Septen)ber 2023 7,696,016 1,929,731 {1,732,812) 16,113 191,700 8,100,748 17,873 8 118621 8,547,106 2J78.650 (2,471.189) (209.917) (548,634 7,696.016 152.030 7 848 046 Unlisted inv¢stm¢nt5 at l October 2022 Addition8 At 30 Septelnber 2023 103 103 103 103 TotAI investments at ¢nd of ye#i' 8,118,724 7,848,149 The charitable coinpaijy owns the entire shale capital (two £1 oiylinary shar¢s) of BSH Enttjprises Limited, a cotnpally registered in England and Wale5. The company organise5 conferences on behalf of the British So¢i¢ty foi. Haemotology. The results of tije company are con501idated in these finaThcial statenients. The charitable eoInpany also owns IOQlo of th¢ share GapEtal (101 £1 oiylinary shares) of The Angel Office Village Ltd, a ¢ompatky Irgistered in Enkland and Wales. 34 Registered company nuJnbEr'. 02645700

The Brit15h So£i¢ty for HfjtJThntology U,Iniii¢J by g¥ArAMteel Noles to tILe finaDCiRI 5tatemen15 (CL7111iiiiiedJ YeAr 30 tscptcmber 2023 16. DEBTORS CIIAI'itsbl¢ compa Group 2023 2022 2023 2022 Due in les8 than one ye Tr8ik (kknrs Pirpayni¢nls aDdaccrued Éncotlle Other taxes Hnd social seuirity AM0￿15 due fromsubsidiaryu￿ertlklll8 17,896 437.194 420.788 420J19 528,059 72,99E 5,640 425,959 420,788 457,201 601,057 in niore th￿ one ye&.: PrepA￿le￿I5 w￿8CcrUcd itKome 11272 11,272 16,407 Told dBbtors 432,060 425,959 468,473 617.464 17. CREDFIDRS: 9niount5 falling duc Chai'i¢blc ¢omp8liy Crvvp 2023 2023 2022 2022 iYÈthith 0￿¢ ytai. T1d¢ cr¢ditors Olber t￿￿¢8 andso¢ial secwity Oih¥F Lrrditors Accr￿18 for grart8 Jxjygblt AccThals anddBfetrcd ÈncoEilC Is¢¢ below) }kn]0v￿ oN%ed to substdisry￿derI￿i￿g 130,577 72 J94 6,121 47,469 207,163 82,693 86,832 6,958 71,337 280.056 131,235 72594 6.121 47.469 212.914 16,832 6,958 Y1,33? 207,208 443,746 463 924 527.876 470 33 Dcferred incom¢ Sul>seriplion incotne Oiher dEfE￿d in¢om¢ Tot815 Accruals Totsl *c¢ru$ls ftnd deferred iiicome 62,765 3.140 55J81 62,765 55.581 4.680 OJ61 152,653 212914 60,261 146 9(k2 207 163 65,905 2J4 151 280 056 141,303 207,208 Deferied subscrEptioJi uiconie OCCUJE as subscriptTOliS are billed based on the ¢alelld&r yeaj., Tliree n?oJitl)s' worth of the 2023 subscription it)corne is deferiEd to the 2023124 f￿an0]HI yeai.. other defEned itjcotne relates to Educational course5 in¢ome received for the nexÉ financial pcriod. 35 Re8isiered ¢omp8ny ttumber.. 02645706

Tlie Sritisli Socicty, fibl. IIRomattslvgy ILimiteiE by gvarnt¢tl NDtes lo Ihc finlllleial sttomtnls (coittriJ3iied) YeAr eDdtd 30 Seplember 2023 18. TOTALFUNDS DesignAltJ fu￿￿5 Gellei'al fllDd5 Ti)tHi 2023 CrTriip At l Oclob¢i' 2022 Net li￿oMe11¢￿pen&itll[eI REV￿li￿10￿0f iiiNtslnienl.4 Inolr 151 Traiisfers bettitertf￿th At 30 September 2023 149.885 1208.7831 10,591.437 413,442 207,8L3 446.440 10.766,252 10,741,322 204.659 207.813 387,i42 Chayllahle ¢OlnPAny Al l O¢ioiKr 2022 N¢1 inwm¢l(expei￿SlUFeI Reyaliiation of In￿stI￿nIS li￿1¢ 151 TranSfc￿ irliTrECli fw AI 30 Scptcjnbcr 2023 149,885 1208.7831 10,278,898 140,322 207,813 1446,4401 10.180,593 10,428.783 207,813 446,440 387542 10.568.135 D¢$lgnttd hinils Ntt outgoing 'HTr51ci'5 frikml i'estTVts (tol Ge￿tr81 BAIRnce &1 30 Sep2023 Oct 2022 Group and elEAril&bEe eompDy Glob￿ l.laeni8tology wilkn￿oi￿ Beqllesl Cijhort Study ID8t$R¢¥i$iryProjecl F￿d) BlooclCgfj¢¢r UK Flind R¢giDiial E'ycnts Siipwrl Fund H￿￿￿ogIc￿ WDikfnTce sI￿Y Proj¢¢i AT fe110Th51)IpAiYdtds Thta15 34.079 21,675 51,733 22J98 20.000 140.5191 6,440 51.733 122,3981 20,000 204,278 90.000 387.542 1145,7221 350.000 149 8¥5 208,783 446 440 The Global Haeniatology Fund had been s¢t up 85 a desiyated funit lo initiate ways olhelping ha¢inatolo8y pIDfessioDals in low and middle income coutitrits. The atÉginal funds Set aside have now be¢ii depleted and this air& of suppoil will bc now be tyeated as a Special Inteirst Group within CTeneral I,unds. The Wilkinson Bequest is a designated fund which pays foi. the Sii. John Da¢1¢ LeGture at the ASM ¢a¢h ycar. Sia]ce the Workfoire Report was pllhlihed in 2020, the BSH has ¢ointlli55ioned a major resta￿h pi'oject to investigate the current stale of the haem&tology woi'kfoi'¢e, thc wellbeing ofihe miiltidis¢iplinary teain (h￿D￿ and how 8ood pla￿l¢e Can help the workfoire GriSiS' the Board liave set aside funds of £350.000 towards this project. Tlie Research and Grants Committee is respottsiblc for administering the following Designated Funds thal have been sel ttp iii iY¢ent yeJi%', The Cohort Study (DAta R¢gi5tsy Project) Flind- set lip to support cohort studies. Th¢ illoney has beeEJ used as part of tlie Society's research piDgixEniiie, Ind tli¢ final award will be paid Èo the year ended Septen)ber 2024. Blood Cancer UK Funds- £150,000 had b¢rn designated to contribute towards a project carrying out researcli into efyjcacy of ¢ovi(I va¢¢ine foi. people with blood ranGer' the f￿2[ payment of £22.398 lias been paid this year to Bl¢x)d Can¢er UK. Regional F.ventS 5UPPOrt- to 5UPPOrt edueation acros5 Iht UK. BSH members will be able to apply to the fund to support inttiatiVe5 ill their part tFf the county. In September 2023 tlie Boaixl agreed to ￿nd two BSH fellows to work part time, for a ye&i' on Al Pi￿le¢15 specifEcally aligned with clinÈ¢al haematology, in partnership wilh the progitmme run by the cli￿1¢￿1 Scientific Coinputing Team based at Guy'5 & St Thon]as' Foundation Ti'ust. 36 Registered compgny nuniber.. 02645706

The Brilisli SociLty for HaEllliltoloEY ILimilEd by EuxfAnt¢¢l Nots to the fihnrttial statements (eoiiriiyited) YL'ar ¢iidod 30 Stptenikoy 2023 18. TOTALFUNDS PRIOR ITAR De8igrthteth fiind8 GenerAI fuDd¥ Rejtrlcled Fiinds Total 2022 Group Al l October2021 Net inrornell¢xpendi¢iirel REvaluaiionof In￿st￿le￿IS (l￿te 151 Trwlsfcrs bett￿Nfu￿S At 30 September2022 421881 10.951,356 303,802 1758,5511 94,830 10,591,437 11,374,237 125.636 194.8301 149,885 10,741,322 Ch•i'514ble tompany Al l October2O21 Nel ittconTrellCxpenditti￿I Revdiiationof sliTrWtinEnis li￿12 551 T[8￿fer5 bets￿¢￿ fu￿1 At 30 Septemi￿r 2022 422.881 1178,1661 10,775,989 411.345 589,511 194,830 149,885 94,830 0,278,898 10,428,783 DeslgDAted funds Ba12nec at 10¢1202A Nel outgfjljig reserves Ti'aD5fer& fro General f￿ndS BAIANee xt 30 Sep 20Z2 Group A>Jd ¢harllbl¢ eompgny iloH HRcnMtology fund Wi1knn50nBeqi￿SI EJSH 60th LohortSludylD*&KegistryProjecl Fund) Bloodc￿Cer UK knd Genomi￿ E￿i￿allOn Fiind B￿nIs sUpportF￿d 48.342 21.795 61,199 101545 120,000 50.ODO 20,000 422.881 1142631 34.079 21,675 116J691 149.8121 197.6021 144,8JOI 51.733 22,398 150,0001 20,000 149.885 TiblAIs 178 166 37 R¢gisÉ¢i'¢d conipgny nurnber.. 02645706

I'h¢ Bi'ilish s￿(jety foi. H4¢J]balDlogi' ILiiY]itÈd by gttRrntce} Noies Iu the finAn£i41 slittinen15 fconlinii¥d) Ycai. ¢nttcil 30 Scptember 2023 ANALYsisof4 GROUP NET A&SE75 BETII'EEN fvNY)S ]ksig￿NtEd Fiinds Thlal 2023 nd$ Fiittds Fiind b•l#v¢es Rt30 SepteJDbeJ' 2023 are repJ'tgÈrtlcd by- T¥n8ibk fixed ￿5¢18 Iiivcsimeitts ￿Se￿ (li￿lISticS) Ai 30 Sei¢tiib¢r 2023 405.941 8.118,722 2.241.559 10.766 252 405,941 8,118,722 2,629,13& 387 542 387 42 ANAL￿￿8 Ob CROUP NET ASSE13 BETITrTEN FUNDS- PRIOR YFAR DesignAt¢d rtd$ General Res11'icted 2022 bAIRllCt% Al 30 septr￿bcr 2022 aTe ble fixed asse In￿tIne￿I5 CurreIii ￿se1$ Iliabtliticsl At30 SEpteni￿r 2022 421,263 7,848,147 2 322,027 10 591,437 421,263 7,848,147 2,471 912 10741322 149.885 149.885 20. OPERATINC LEASE COMMITMEI NTS As at 30 Septemb¢r 2023. tlie tharity and giDUP'S ￿tUre miniii1￿llI op¢r&ting lease payinents are as follows.. 2023 ChRrity 1022 Charaty Group Croup Offjtt Equipment Within one year Bet￿r¢n and yEar5 719 1.032 1,751 719 1,032 854 1,032 854 1.032 1,886 The amoullts chRrged to the Statement of Financial Activities in tli¢ year was £1,538 (2022.. £1.4121 38 R¢gisrcy*d comp&ny nvtnber.. 02645706

The Bi'it15h Sofiety for H￿eni￿t0]￿gY ILimited by EufAlit¢c} Notes tlie finneSal slaltmeLts (LY)iiliiiiiedJ Yt%J' tndtd 30 Stplcmbcr2023 21. PENSIONS The Charity cOntrib￿tE5 to the ]%JEST pen55on 5theme. This 15 a dcfllied contribution scheme, contributions are ade in ac¢ordance with thc Jwles of the plan and are chai'ged to expenditiire when they are payable. Confributiolls to the scheme tolalled £39,740 {2022'. £33,345). At the year end ¢Olltribution8 totallijig £5,191 (2022.. £4,250) were outstonding. 22. RELATED PARTY TRANSACTIONS No related party transactions took place in the year (2022.. th)ne). POST BALANCE SHEI ET El/TNTS Tow&i'ds the end of the financial year I'ht UK Fonim {a Tegistered charity) had agreed lo close, transferriiig theii. funds and expertise into a Special Interest Group withiii the BSH. As Closure proceedings weTe takii)g place the UK MDS Foium received a consideiable legacy and the ex¢¢utors of tl)c bcncfactor's W￿11 liave coijfiimed tliat the futjds will l)c passed to ihe RSH to turther the ￿SEarch into Myelody5plastic syndrome. After the year et)d the BSH received tlie legacy of £150,000. 39 Reg￿tered compBlly iiumber.. 02645706

The Brili511 SDL'iety for HaemAtology ILimilt(I by giiarajileel CoiLsolldAted s¢Attmertt of fJnaiiL'i#I qetii'ities Ycar ciidcil 30 Stptember 2023 24. PRIOR YEAR STATEMENTOF VINANCIALACIINTnES Gejieral D¢8ignAte Fun¢l$ Total k)tes 2D12 lTrtomt from Do]iatiOll5 Chaiilable aclivilies.. si1￿Crip110nS Profil shere of British loiirngj Of HaeJnaLoIo8y 011￿r income Jncorne froni the opei'stiollof confer¢nc¢s InTrBslniEJrt itwme TotHI kncoint 705 705 233,868 233.B68 1,144,431 307 1.175.034 52,465 2606810 307 ,175,034 52,465 2 606,810 EXPENDITURE ON.. Rwsing fwiLts In￿￿1[￿¢111 tnan3gell￿nttees 35,855 35,855 R¢seweh Edut&ionandawar¢n¢ss Co$lot"QPBraiionof ¢onf¢rellc¢s 618 135,343 161,677 16,489 297,020 .134,075 .014,224 ,OL4,224 Toixl cxpcllditliTe 2,303,008 178 166 2481174 Net 1￿Come btfort lJkVtsmtnl Enins tra￿￿rerS 303.802 1178,1661 125,636 Nei gans on invèsttDents 1758,5511 1758,5511 Nel inCOmE net UkoveDJent5 IR fllnd5 1454,7491 (632,9151 That￿reT betwten fi 94,830 {94.8301 Recollciliation of Futklbaiances brought foiwdrd 10,951,356 422,881 ,374.237 Fund b9J9JJc¢s ¢￿i¢d for¥wd 10591437 149,855 10.741 322 All recognised gains and losses arc refie¢t¢d throu8]i tlie Statejnent of Fiiiancial Activities. All activities I'efle¢ted above air continuing activities. 40 Regislered company number.. 02645706